Podcasts about oncology nursing society

From Nurse to Oncology Sales: Catina Pitzen's Journey   What does it take to go from bedside nurse to top oncology sales rep? In this episode of Medical Sales U, I sit down with Catina Pitzen, Senior Oncology Sales Representative at Eisai and board member of the Columbus chapter of the Oncology Nursing Society.   Catina shares how her nursing roots—especially her love for labor and delivery—prepared her for success in one of the most complex areas of pharmaceutical sales.   We discuss the realities of breaking into oncology, the power of pre-call planning, and how her commitment to lifelong learning shapes her approach. Whether you're a nurse considering a new career or a sales professional exploring oncology, Catina's story is a powerful reminder that clinical experience and curiosity can open doors in medical sales.

Host: Mindy McCulley, MS Family and Consumer Sciences Extension Specialist for Instructional Support, University of Kentucky  Guest: Susan Yacksan, PhD, APRN, AOCN Enterprise Director of Service Line Performance Management, UK HealthCare Cancer Conversations Episode 64 Join us on Cancer Conversations for an insightful discussion with Dr. Susan Yacksan, the Enterprise Director for Service Line Performance Management with Markey Cancer Center, as we take a look at the multifaceted world of oncology nursing. Discover the different pathways to becoming an oncology nurse, the various subspecialties such as medical, surgical, and GYN oncology, and the certification processes involved. Dr. Yacksan shares her extensive career experiences, from academic medical centers to community hospitals, emphasizing her passion for patient relationships and the scientific approach needed in cancer care. If you are considering a nursing career or want to explore oncology, learn about the impact of this specialty and the opportunities available through the Oncology Nursing Society. Yacksan Article on UKNOW Connect with the UK Markey Center Online Markey Cancer Center On Facebook @UKMarkey On X @UKMarkey

Join Rebeca Leon on this episode of the Nurse Converse podcast as she pulls back the curtain on the world of oncology nursing. She shares her personal journey into this life-changing specialty, reflecting on the emotional highs, the profound patient connections, and the powerful community of oncology nurses. Get inspired by highlights from the 50th Oncology Nursing Society Congress and discover why this field is more critical than ever. If you've ever wondered what it's like to make a difference in the lives of cancer patients, this episode is for you. >>Inside Oncology Nursing: Stories, Challenges & Triumphs from the Frontlines of Cancer CareJump Ahead to Listen: [01:08] Oncology Nursing Society's 50th anniversary.[05:10] Oncology nursing specialties and settings.[10:57] Oncology nurses' resilience and care.[13:57] Attending oncology nursing conferences.[17:51] Customizing conference experiences for nurses.[23:45] Immunotherapy in oncology nursing.[26:00] Advancements in oncology nursing.[30:07] Oncology nursing opportunities for students.[34:37] Oncology nursing community connection.Connect with Rebeca on Social Media:Instagram: @EnfermeraMami.RNFor more information, full transcript and videos visit Nurse.org/podcastJoin our newsletter at nurse.org/joinInstagram: @nurse_orgTikTok: @nurse.orgFacebook: @nurse.orgYouTube: Nurse.org

Effective oncology care thrives on collaboration, and in this episode, we're joined by two trailblazing oncology nurses, Elizabeth Bettencourt, MSN, RN, OCN, and Mary Anderson, BSN, RN, OCN, who share their wealth of experience and passion for improving cancer care. Together, they introduce a newly developed Positive Quality Intervention (PQI) within the Oral Anticancer Medication (OAM) Care Compass—a collaborative resource created with the Oncology Nursing Society to enhance interprofessional teamwork and streamline oral anticancer medication workflows.Elizabeth and Mary take us inside the process of mapping oral oncolytic workflows, breaking down how this PQI can improve team-based care, patient adherence, and overall safety. More than just a structured approach, this initiative represents a commitment to ensuring that every patient receiving oral anticancer therapy is fully supported by a well-coordinated healthcare team.This episode goes beyond workflows and best practices—it's about the people behind the care. Elizabeth and Mary bring their deep understanding of oncology nursing to the conversation, shedding light on how interprofessional collaboration can truly transform patient outcomes. Whether you're a nurse, pharmacist, or part of the oncology care team, you'll walk away with both practical insights and a renewed appreciation for the dedication that fuels high-quality cancer care. Explore the Resources:Oral Anticancer Medication Patient Management Workflow Evaluation and Process Mapping PQIOAM Care Compass  About the Guests:Elizabeth Bettencourt, MSN, RN, OCNWith more than 30 years in oncology, Elizabeth has dedicated the last 13 years to creating a comprehensive oral oncolytic program at Palo Alto Medical Foundation/Sutter Health. Her program, which has touched countless lives, weaves together prescription processing, education, and ongoing patient monitoring to ensure the best possible outcomes for patients battling cancer. Elizabeth's approach is a testament to the power of creating systems that truly support both patients and the oncology care team.Mary Anderson, BSN, RN, OCNMary's 36 years in oncology nursing are defined by her commitment to improving patient care and safety. Her journey, shaped by the struggles she saw patients face with oral anticancer medications, led her to develop critical interprofessional processes to enhance adherence and care. Now serving as the Senior Manager of Nursing Initiatives at NCODA, Mary's mission is to equip oncology nurses with the tools and confidence they need to provide exceptional, compassionate care. Her passion for empowering others shines through in everything she does. 

MDJ Script/ Top Stories for March 26th Publish Date:  March 26th    Commercial: MONSTER JAM 2025_FINAL From the BG Ad Group Studio, Welcome to the Marietta Daily Journal Podcast.    Today is Wednesday, March 26th and Happy Birthday to Diana Ross ***03.26.25 - BIRTHDAY – DIANA ROSS*** I’m Keith Ippolito and here are the stories Cobb is talking about, presented by Times Journal Lawmakers decide to ban cellphones in public elementary and middle schools Kennesaw Grand Prix 5K Series Returns For 2025 'We can't do our jobs': Some Cobb Servers Still Down After 'Unusual Activity' Spotted All of this and more is coming up on the Marietta Daily Journal Podcast, and if you are looking for community news, we encourage you to listen and subscribe!  BREAK: MONSTER JAM 2025_FINAL STORY 1: Lawmakers decide to ban cellphones in public elementary and middle schools Starting next fall, Georgia's "Distraction-Free Education Act" will ban personal cellphone use in public elementary and middle schools, following overwhelming legislative support. The bill, awaiting Governor Brian Kemp's signature, requires students to lock up devices during school hours, with exceptions for medical or disability-related needs. The move addresses concerns about technology's impact on children, echoing global trends like bans in Australia and France. Proponents argue the ban reduces distractions and improves student well-being, while critics worry about communication during emergencies. Discussions may extend the ban to high schools in the future, reflecting ongoing debates about technology's role in education. STORY 2: Kennesaw Grand Prix 5K Series Returns For 2025 The 2025 Kennesaw Grand Prix 5K series returns with four races on a fast, USATF-certified course through downtown Kennesaw and Swift-Cantrell Park. Part of the Fit City Kennesaw initiative, the series caters to competitive runners, beginners, and families, offering a festival-like atmosphere. Races start at Kennesaw First Baptist Church, with a one-mile fun run, 5K, and Tot Trot, followed by awards. The schedule includes races in April, June, September, and October, with early bird pricing and a custom gift for full-series registrants. Registration is open at raceroster.com, and more details are available at kennesawgrandprix.com. STORY 3: 'We can't do our jobs': Some Cobb Servers Still Down After 'Unusual Activity' Spotted Cobb County is grappling with server issues after detecting unusual activity, which officials hesitate to label as a "hack." Several servers were taken offline for maintenance, disrupting internet access, email, and online systems across county offices, including courts and police. Court filings and payments are being processed manually, and employees report limited communication about the situation. Superior Court Clerk Connie Taylor advised bringing hard copies for upcoming hearings, while electronic payments remain paused. Officials hope to restore all servers today, but the disruptions have significantly impacted daily operations. We have opportunities for sponsors to get great engagement on these shows. Call 770.799.6810 for more info.    Break: INGLES 1 STORY 4: Cobb Staff Wants 290 More Employees, $93 Million Boost in 2026 Budget Cobb County's proposed 2026 fiscal year budget includes a $92.7 million increase, largely driven by requests for 290 new full-time positions, down from last year’s 380. Key requests include 113 positions for the Sheriff’s Office as part of a $27 million budget and an $8.8 million increase for Cobb Police. Commissioner Keli Gambrill raised concerns about potential duplication of services. Public hearings on the budget and millage rate are scheduled for late June and July, with a final vote expected after the last hearing. Adjustments may be needed due to the 2025 MLB All-Star Game. STORY 5: KSU Assistant Professor Receives National Honor for Mentorship in Oncology Nursing Kennesaw State University assistant professor Chinomso Nwozichi has received the prestigious Connie Henke Yarbro Excellence in Cancer Nursing Mentorship Award from the Oncology Nursing Foundation. Honored for his dedication to mentoring future oncology nurses, Nwozichi has made significant contributions to cancer care and education globally. Since joining KSU in 2023, he has published extensively, mentored undergraduate researchers, and advanced oncology nursing education as president of the Oncology Nursing Society of Nigeria. His work emphasizes evidence-based care, leadership, and advocacy, earning him recognition as a Fellow of the American Academy of Nursing. Break: MONSTER JAM 2025_FINAL STORY 6: Dobbins Names Kennesaw Mountain Senior Airman for a Day Kennesaw Mountain High School senior Joseph Owens, a former patient at Children’s Healthcare of Atlanta, was named Airman for a Day by the U.S. Air Force’s 700th Airlift Squadron. The event, part of a partnership with Children’s Healthcare, gave Joseph a hands-on experience at Dobbins Air Reserve Base, including fire rescue training, a mock traffic stop, and trying on pilot safety gear. Adopted from Uganda, Joseph overcame severe ear infections and hearing loss with years of treatment, culminating in restored hearing. Now planning to join the U.S. Marine Corps, Joseph said the experience motivates him for his future military career. STORY 7: Tommy Nobis Center Hosts 27th Annual Galaxy of Stars Luncheon The Tommy Nobis Center will host its 27th Annual Galaxy of Stars Luncheon on April 25 at the Cobb Energy Centre, celebrating individuals with disabilities and community leaders who support them. This year’s theme, "Empowered," underscores TNC’s mission to help individuals achieve their career goals. Honorees include Kim Menefee (Lifetime Achievement Award), Laura and Eric Hart (Community Champions Award), and Nolan Wilson (Rising Star Award). The event features an online auction starting April 4, with proceeds funding programs for youth and adults with disabilities. Cobb EMC Foundation is the Presenting Sponsor. Break: MONSTER JAM 2025_FINAL Signoff-   Thanks again for hanging out with us on today’s Marietta Daily Journal Podcast. If you enjoy these shows, we encourage you to check out our other offerings, like the Cherokee Tribune Ledger Podcast, the Marietta Daily Journal, or the Community Podcast for Rockdale Newton and Morgan Counties. Read more about all our stories and get other great content at www.mdjonline.com Did you know over 50% of Americans listen to podcasts weekly? Giving you important news about our community and telling great stories are what we do. Make sure you join us for our next episode and be sure to share this podcast on social media with your friends and family. Add us to your Alexa Flash Briefing or your Google Home Briefing and be sure to like, follow, and subscribe wherever you get your podcasts. Produced by the BG Podcast Network Show Sponsors: www.ingles-markets.com www.monsterjam.com/en-us #NewsPodcast #CurrentEvents #TopHeadlines #BreakingNews #PodcastDiscussion #PodcastNews #InDepthAnalysis #NewsAnalysis #PodcastTrending #WorldNews #LocalNews #GlobalNews #PodcastInsights #NewsBrief #PodcastUpdate #NewsRoundup #WeeklyNews #DailyNews #PodcastInterviews #HotTopics #PodcastOpinions #InvestigativeJournalism #BehindTheHeadlines #PodcastMedia #NewsStories #PodcastReports #JournalismMatters #PodcastPerspectives #NewsCommentary #PodcastListeners #NewsPodcastCommunity #NewsSource #PodcastCuration #WorldAffairs #PodcastUpdates #AudioNews #PodcastJournalism #EmergingStories #NewsFlash #PodcastConversations See omnystudio.com/listener for privacy information.

“The response was, in my opinion, sort of overwhelmingly positive. I think all of us old-timers who were at ONS Congress® in 1986 remember those 1,600 nurses waiting in line to enter the ballroom to take that inaugural exam. It takes a while to check in 1,600 people. They kind of all filled up the lobby outside of the ballroom, and then they spilled over down into the escalator, and the escalators had to be turned off,” Cyndi Miller-Murphy, MSN, FAAN, CAE, first executive director of the Oncology Nursing Certification Corporation (ONCC), told Clara Beaver, DNP, RN, AOCNS®, ACNS-BC, ONS member and member of the ONS 50th anniversary committee, during a conversation about the evolution of oncology nursing certification. Beaver spoke with Tony Ellis, MSEd, CAE, ICE-CCP, executive director of ONCC, and Miller-Murphy about the history, current landscape, and future of certification in oncology nursing. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Episode Notes  NCPD contact hours are not available for this episode.  ONS Podcast™ episodes: Episode 254: Oncology Nursing Certification Affects the Entire Cancer Care System Episode 186: Certification Can Fuel Your Leadership Skills and Professional Growth ONS Voice articles: Certification Was a Critical Step Along My Oncology Nursing Career Journey OCN® Certification Test-Taking Tips to Ease Your Anxiety ONS books: Advanced Oncology Nursing Certification Review and Resource Manual (third edition) Breast Care Certification Review (second edition) BMTCN® Certification Review Manual (second edition) Core Curriculum for Oncology Nursing (seventh edition) Study Guide for the Core Curriculum for Oncology Nursing (seventh edition) ONS courses: OCN® Certification Review Bundle ONS AOCNP® Certification Review Bundle™ Clinical Journal of Oncology Nursing article: Findings From the 2023 Radiation Oncology Nursing Role Delineation Study to Shape the Future of the Subspecialty Oncology Certification for Nurses: Joint Position Statement From the Oncology Nursing Society and the Oncology Nursing Certification Corporation ONCC website Connie Henke Yarbro Oncology Nursing History Center To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode Miller-Murphy: “Oncology nursing is a highly specialized area with a broad, well-defined body of knowledge, and it's essential for employees and healthcare consumers to be able to identify nurses who have demonstrated that they possess the knowledge that's necessary to practice competently in the specialty. Nurses who become certified take that essential step to publicly demonstrate their knowledge. And I believe this makes them a known commodity, so to speak.” TS 1:49 Ellis: “Oncology nursing is an area of high-stakes patient care, and a core purpose of certification is to safeguard the public. This is certainly an area of health care that benefits from having that role of professional certification being played, from the knowledge requirements to the practice hours that a nurse must have, to the performance on the exam and continued competence required to maintain the certification. Our certifications hold nurses to a higher standard, which helps protect the public in the care that they provide.” TS 2:45 Miller-Murphy: “A group of, I think, 200 nurses got together at an American Cancer Society conference back in 1980 to discuss the desire for certification in ontology. Nurses wanted a way to verify their specialized knowledge and skills. They wanted to raise the level of professionalism, and ONS was the most appropriate organization to develop the certifications. And by 1983, a survey of members revealed strong interest in specialty certification in oncology.” TS 5:29 Ellis: “The pace of change in oncology care is really the challenge for certification programs proper right now. There's so many wonderful advances—oncology treatments and drugs that are coming to the market that are being used in non-oncology settings and other advancements in the practice, that keeping up with that change puts pressure on certification programs because they must validate knowledge and practice that has become standard. It has to have been in the practice long enough that whatever the content, whatever the practice is that you're testing on, that there is one single correct answer. So you can't necessarily test on the very latest of what has come to the market or to the practice. The other flipside of that is that pace of change, the new emerging things in the practice create opportunities for other kinds of credentials.” TS 24:31 Ellis: “What we have found is that there are thousands and thousands of oncology nurses that are practicing at a level and doing specialized work beyond the scope of the OCN® body of knowledge—so at the master's level, PhD, especially with the advent of the DNP, and there is work there. And this really came out of our work to update the advanced oncology nurse competencies. … So the new certification is the Advanced Certified Oncology Nurse, or the ACON. In certification, and it is suited for those nurses that are practicing at that higher level.” TS 32:52

In episode 181 of the Thyroid Answers Podcast I have an conversation with Nurse Practitioner Tara Quintana on strategies for thyroid recovery. In this episode we discuss: Tara's amazing thyroid story. Why optimizing blood levels with hormone replacement is often not the answer for thyroid recovery. Why common protocols do not often work as hoped. Strategies for creating a healing mindset. Tara's Hashimoto's Recovery Blueprint And more... Tara Quintana is a Board Certified Family Nurse Practitioner with over 12 years of healthcare experience. She completed her Master of Science in Nursing at Purdue University Global, graduating with honors. Seeing the need in healthcare for root cause medicine, she became a certified practitioner through the Institute of Functional Medicine. Tara then opened her own practice, The Functional Nurse Practitioner, LLC, where she specializes in root cause medicine. Tara began seeing similar issues coming to light over and over again, immune system dysregulation, which led Tara to go back to school to better understand how to serve those with these issues. Tara was certified as a Master Level Nutrition Consultant, Certified Holistic Nutritionist, Gut Health Certified Nutrition Specialist, and Certified Weight Loss Specialist. In her second practice, Quintana Functional Wellness, LLC, Tara partners with her clients utilizing holistic nutrition and wellness coaching to assist those battling with Hashimoto's disease. As the creator and host of The Functional Nurse Practitioner Podcast and the creator of the Hashimoto's Recovery Blueprint. Tara provides valuable education and support to her community. She is a member of the American Academy of Nurse Practitioners, Oncology Nursing Society, and Alpha Beta Kappa Honor Society. https://www.quintanafunctionalwellness.com/  

“The gravity of the responsibility was realized when you walked into the boardroom and you're there to make decisions, and the perspective you have to take shifts. Of course, I bring to the table my expertise and my perspective, but the decision-making and strategy behind it is really geared at sustaining the organization and moving us towards our mission, which is to advance excellence in oncology nursing and quality cancer care. Being able to reframe your perspective a little bit around those decisions is something that you don't realize until you're there to do that,” ONS director-at-large Ryne Wilson, DNP, RN, OCN®, told Brenda Nevidjon, MSN, RN, FAAN, chief executive officer at ONS, during a conversation with the three new 2024–2027 directors-at-large on the ONS Board. Nevidjon spoke with Wilson, Heidi Haynes, MN, CRNP, OCN®, and Susan Yackzan, PhD, APRN, AOCN®, about their careers, paths to serving on the Board, and passions in oncology. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.75 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by November 15, 2026. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: The learner will report an increase in knowledge related to the key roles of the ONS Board of Directors. Episode Notes  Complete this evaluation for free NCPD.  Oncology Nursing Podcast™ episodes: Episode 270: Meet the ONS Board of Directors: Brown, MacIntyre, and Woods Episode 239: Meet the ONS Board of Directors: Allen, Mathey, and Robison Episode 224: Meet the ONS Board of Directors: Nevidjon, Geddie, and Garner Episode 213: Meet the ONS Board of Directors: Brant, Burger, and Knoop Episode 200: Meet the ONS Board of Directors: Houlihan, Ferguson, and Polovich ONS Voice articles: Climate Change Is Contributing to the Cancer Burden, and Nurses Must Take Action Mentorships Open Opportunities for Oncology Nurses' Career Growth and Wellness Oncology Nurse Joins Panel to Discuss Solutions to Advance Equitable Cancer Care for the LGBTQ+ Community Seeds Planted Today Nurture a Harvest of Future Generations of Oncology Nurses Find Your Voice With ONS's Leadership Development Committee ONS courses: Advocacy 101: Making a Difference A Guide to Chapter Leadership: Chapter President Training A Guide to Chapter Finances: Chapter Treasurer Training Board Leadership: Nurses in Governance ONS Leadership ONS Leadership Learning Library ONS Network and Advocacy Resources Joint Position Statement from APHON, CANO/ACIO, and ONS Regarding Fertility Preservation in Individuals with Cancer To discuss the information in this episode with other oncology nurses, visit the ONS Communities. To find resources for creating an Oncology Nursing Podcast Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode Wilson: “After graduating and moving to Minnesota, I immediately joined the Southeast Minnesota chapter of the Oncology Nursing Society and served on the board and a few different positions, as membership chair and as the legislative liaison for the chapter, as well. And I had the opportunity to go to my first ONS Congress®. That really opened my eyes to all of the possibilities and all the really incredible work that so many of our colleagues across the country have been doing, which really was inspiring and really made me want to do more. I took on more volunteer opportunities within society—things like the OCN® Passing Score Task Force with ONCC, as a Biomarker Database expert reviewer, the Symptom Intervention Guidelines reviewer, and several other volunteer opportunities, just to stay connected and build relationships, but also give back to the profession that had really given so much to me.” TS 10:06 Haynes: “What I've been learning is how to transfer that passion and leadership experience that I learned at the local level and grow them into bigger-picture skills, sort of switching my hat and supporting our oncology nurses on more of a global level. I would say for those interested in a national Board position but unsure how they would navigate being new to the role, I can tell you the personal support of the new Board members has been wonderful. Brenda, you and the more senior members of the Board and the National ONS team have all been welcoming and willingly share their knowledge. We even get assigned a Board buddy, and I have to give a shoutout to my Board buddy, Trey Woods, who has graciously—more than graciously—put up with all of my questions and pestering along the way.” TS 16:39 Yackzan: “Well, the health of the organization is a responsibility. So that's what you're giving yourself over to and the task. The chapter board is just on a much more local and scaled back level. I mean this reaches a different proportion. So, you know, it's not that it was the prior. I just think the full impact of it sort of comes to you when you're in the Board meeting and you're thinking through those things. The budget committee is one of the committees that I'm on, and I'm happy to report that we're very healthy. And that's because of the great stewards who came before me, and so, like everybody else on the Board, we feel the impact of making sure that that continues because oncology nursing is essential. We must continue to go forward.” TS 18:18

“It's not often in life that you find something that gives you this feeling, but I'm really so fortunate to have found mine, and I know this is only just the beginning, and I cannot wait to see what the future holds. I definitely owe a lot of that to the Oncology Nursing Society for opening up all those doors for me and really getting me into this field.” Samantha Paulen, BSN, RN, told Jessica MacIntyre, DNP, MBA, APRN, AOCNP®, 2024–2026 ONS president, during a conversation about student nurses entering the oncology field. MacIntyre spoke with Paulen and Tayler Covino, BSN, RN, both recent graduate nurses, about why they chose oncology nursing as a specialty. Music Credit: “Fireflies and Stardust” by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Episode Notes  NCPD contact hours are not available for this episode.  Oncology Nursing Podcast™ episodes: Episode 191: Explore Orientation Opportunities for New-to-Practice Nurses Episode 20: Advance Your Career Through Awards, Grants, and Scholarships ONS Voice articles: Nursing Students Connect Beyond the Classroom With ONS Resources One Oncology Lecture Isn't Enough Nurse Residency Programs Improve New Graduate RNs' Transition to Clinical Practice Train and Retain: From Orientation to Leadership, Here Are the Strategies That Experienced Staff Developers Use Innovative Programs Help Institution Grow Its Own Nursing Workforce Oncology Nurses Enhance Cancer Care Through Mentorship Opportunities Nursing Team Shares Process of Training a New Nurse in Oncology Outpatient Care ONS book: Cancer Basics (third edition) ONS courses: ONS Cancer Basics™ ONS Cancer Biology™ ONS Oncology Nurse Orientation Preceptor Bundle™ Clinical Journal of Oncology Nursing articles: American Association of Colleges of Nursing: New Essentials, Quality and Safety Domain Can a Recent Nurse Graduate Thrive in the Oncology Setting? Prelicensure Nursing Students' Attitudes Toward Patients With Cancer Revisited ONS Learning Library: Nurse Orientation ONS Undergrad/Pre-Licensure Core Competencies ONS Career Guide ONS Resources for Student Nurses To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an Oncology Nursing PodcastÔ Club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode “I was first drawn to oncology nursing freshman year of high school when my grandmother, who was my ultimate best friend, was diagnosed with pancreatic cancer, and by the time they had caught it, it had metastasized to nearly every surrounding organ. And as I mentioned earlier, my grandmother was a nurse. So being a nurse, she was very stubborn, and when she finally had gone to the hospital after having a variety of symptoms, it was almost too late.” (Paulen) TS 7:27  “There's really nothing more special to me than being able to develop relationships with my patients and support them throughout their journey. It's incredibly rewarding making such a difference in their lives and being able to witness the strength and resilience of patients battling cancer, and it's such an inspiration. Being able to provide my support both medically and empathetically is truly such an honor.” (Paulen) TS 10:04  “I also had a family member who was diagnosed with cancer. He was my uncle. And I witnessed firsthand the impact that compassionate and knowledgeable oncology nurses had on his treatment, and it really did leave such a lasting impact on me. … This experience deeply inspired me, and I just always wanted to be part of a team that offers hope and comfort to their patients and their families.” (Covino) TS 12:10  “I touched on my pediatric oncology clinical rotation, but I really do think it gave me insights into caring for younger cancer patients. This experience really emphasized the importance of a holistic approach to nursing, considering not just medical but also the emotional and developmental needs of children who are battling cancer.” (Covino) TS 24:05 “I also joined ONS as a student, so it was a large part of my college education and really gave me great access to resources, being able to attend meetings, and just stay updated on the latest in oncology nursing with the articles that they send out and just provided me with great networking opportunities with so many experienced oncology nurses who have such a wide breadth of knowledge.” (Covino) TS 24:27 “Practicing mindfulness and meditation has also been incredibly helpful in staying grounded and managing the emotional stress. These practices help me stay present. They reduce anxiety and maintain a positive outlook, even in these challenging environments. It's really important to just set emotional boundaries as well to avoid burnout.” (Covino) TS 33:05 “There's such a fulfillment that you get for making a significant impact on patients' lives, and that's what inspires me and should inspire others to consider this specialty. There's also a lot of growth opportunities, and I think it's really important to emphasize the growth opportunities within the field. And also just the advancements in cancer treatment can attract new nurses because there really is so much advancement in the field of cancer treatment.” (Paulen) TS 42:59  “I feel that specifically in this specialty, oncology nurses in particular are so much more willing to help versus they say that sometimes some nurses may eat their prey or whatever they might say. But I really think that oncology nurses are so willing to help, but sometimes you just have to really expose yourself and open up that door.” (Paulen) TS 45:07 

In this episode, we chat with Katrina Loutzenhiser, Director of Learning and Development at Oncology Nursing Society, about challenges in providing learning and development to a member organization, motivating people to engage in DEI work, and integrating DEI into the workplace. We also discuss our involvement with ONS as clients and share insights from our recent work together. [00:00:50] Clients as podcast guests.[00:04:25] Interview with Katrina starts.[00:06:25] DEI Journey[00:10:55] Tying bonuses to diversity training.[00:13:50] Mandatory vs voluntary training.[00:18:13] Engaging in lunchtime conversations.[00:21:27] Impact of Five Minute Conversations.[00:24:06] Importance of post-training work.[00:28:44] Intersection of L&D and DEI.[00:32:06] Knowledge checks.[00:37:10] Future goals and aspirations.[00:40:44] Meaningful job for women. Links mentioned:Contact Katrina via email at kloutzenhiser@ons.orgONS website Visit us at https://shegeeksout.com to stay up to date on all the ways you can make the workplace work for everyone! Check out SGOLearning.com and SheGeeksOut.com/podcast for the code to get a free mini course.

In this episode of Navigating Cancer TOGETHER, host Talaya Dendy celebrates Juneteenth and National Cancer Survivor Month. She discusses a study by the Oncology Nursing Society on the therapeutic effects of digital storytelling for cancer survivors. Special guest Stephanie Y. Cole, a master storyteller and caregiver, shares her insights on the importance of storytelling in healing and connection. Stephanie recounts personal anecdotes, including a touching moment involving her mother's hospitalization during the pandemic and a humorous story about matchmaking on a New York City train. The episode highlights how storytelling can provide hope, healing, and a sense of community for those facing major illnesses, such as cancer.✨Highlights from the show:[00:21] Study on Digital Storytelling for Cancer Survivors[05:47] Stephanie's Storytelling Journey[09:57] The Emotional Rollercoaster of Caregiving[24:56] The Healing Power of Storytelling[36:32] The Power of Storytelling in Coping with Illness[38:30] Facing Cancer with Courage and Resilience[43:45] A Heartwarming Train Encounter[53:10] Introducing the Audio Oasis Podcast[01:05:56] The Importance of Sharing Your StoryReflection: How did this episode make you feel about the stories you have inside of you?

This playlist features live interviews recorded by Oncology Data Advisor at the 49th Annual Oncology Nursing Society (ONS) Congress in Washington, DC. For more information, visit OncData.com.

Episode 155 is another Q&A session. My co-host for this podcast is Tara Quintana. Tara is a Board Certified Family Nurse Practitioner in Indiana. If you have questions about thyroid health, these Q&A episodes may answer your burning questions as well.  If you have questions you want answered, you can submit them to office@rejuvagencenter.com with the subject line Thyroid Answers Podcast Questions. Tara Quintana is a Board-Certified Family Nurse Practitioner and licensed in Indiana. She completed her Master of Nursing Practice Degree at Purdue University Global, graduating with honors while working as an RN in Monroe and surrounding counties. She has ten years of experience as an RN, dedicated to providing personalized and compassionate care.   Working in Women's Health, Tara provided exceptional care, focusing on wellness and disease prevention. With the state of our national healthcare system and the incredible need for personalized medicine, Tara felt compelled to go back to school and study at The Institute of Functional Medicine. The rigorous program was very challenging and fueled Tara's continued desire for evidence-based medicine, leading to the creation of The Functional Nurse Practitioner Podcast. Tara spent countless hours studying root cause medicine and was certified as a functional medicine practitioner through IFM.   Tara began incorporating functional medicine methodologies within her Women's Health practice, and the results were phenomenal. She continued pushing the barriers of conventional medicine, until it became apparent that a truly personalized approach needed more. Tara opened her own practice, The Functional Nurse Practitioner, LLC, and has not looked back. Specializing in root cause medicine, Tara takes a different approach, unraveling each client's unique story in order to facilitate optimal health. Tara's podcast continues to provide an exceptional education for her community, and her platform is highly regarded within the health and wellness space. Tara has many plans for the future regarding educational, nutrition, and coaching programs, as wellness is at the forefront of her business. Tara is an active member of several professional organizations including the American Academy of Nurse Practitioners, The Institute of Functional Medicine, Oncology Nursing Society, and Alpha Beta Kappa, the National Honor Society, by election of the Delta Zeta Chapter. Tara and her husband, Tom, reside in Ellettsville, Indiana. She enjoys cooking, fitness, mountain biking, and spending her free time traveling to both favorite and new bike destinations.   https://thefunctionalnursepractitioner.com/  

When a person is told they have breast cancer, there are many emotions that come from that diagnosis, including grief and fear. Lisa Chism is very aware of these emotions and the way they continually show up throughout the journey of battling breast cancer. This is why she looks at the whole picture with those affected by this diagnosis – from their sex lives, care and well-being, and how menopause or perimenopause is affecting them. In this episode, Kara and Lisa discuss the many things a person can experience with breast cancer and how to advocate to get the best care they deserve.  Lisa Chism holds a Doctorate of Nursing Practice (DNP) and is the clinical director of Oakland Macomb Center for Breast Health. She holds three specialty certifications which include certification as a Menopause Practitioner through the Menopause Society, certification as sexuality counselor through the American Association of Sexuality Therapists, Counselors and Therapists (AASECT), and after 15 years caring for breast cancer survivors and patients at high risk for breast cancer, she became certified in breast care through the Oncology Nursing Society. Lisa has established a dedicated menopause and sexual health clinic caring for the menopausal and sexual health needs of women who have a history of breast cancer or are at elevated risk for breast cancer.  Lisa has authored numerous publications related to women's healthcare including serving as lead author of the 2023 Menopause Society's Non hormonal position statement. She guest lectures at universities across the country and her textbook The Doctor of Nursing Practice: A Guidebook for Role Development and Professional Issues is in its fifth edition. She is a Fellow of the American Association of Nurse Practitioners and was selected as Menopause Practitioner of the year 2011. She formally served on the Board of Directors at the North American Menopause Society as well as a federal advisory committee with the CDC regarding breast cancer in young women. In October 2021, Lisa Chism was inducted as a fellow of the American Academy of Nursing. Learn more: Oakland Macomb Obstetrics & Gynecology Provider Profile North American Menopause Society International Society for the Study of Women's Sexual Health

In a conversation with CancerNetwork®, Sarah Donahue, MPH, NP, discussed strategies for managing adverse effects (AEs) associated with different drug classes for patients with metastatic breast cancer, ranging from antibody drug conjugates (ADCs) to CDK4/6 inhibitors. With respect to ADCs, Donahue, a nurse practitioner at University of California, San Francisco, and member of the Oncology Nursing Society, highlighted common AEs following treatment with trastuzumab deruxtecan (T-DXd; Enhertu) and sacituzumab govitecan-hziy (Trodelvy). In particular, she spoke about the necessity of managing nausea associated with T-DXd by helping patients schedule doses with antiemetic drugs, as well as mitigating fatigue and improving quality of life in the process. For those who are treated with sacituzumab govitecan, Donahue spoke about mitigating abdominal cramping at her infusion center and administering loperamide to help patients manage acute diarrhea. Donahue also discussed her methods for managing toxicity related to CDK4/6 inhibitors including palbociclib (Ibrance), ribociclib (Kisqali), and abemaciclib (Verzenios). Among patients with hormone receptor (HR)–positive breast cancer, treatment with palbociclib and ribociclib, when given in combination with hormonal therapy, may result in fatigue, hot flashes, and arthralgia. According to Donahue, encouraging patients to exercise often may combat fatigue while mitigating arthralgia associated with an aromatase inhibitor. Moreover, she stated that loperamide may help manage potential diarrhea following treatment with abemaciclib.  Overall, Donahue underscored the importance of keeping patients on treatments with CDK4/6 inhibitors and other treatments by being communicative with them regarding the potential to alleviate AEs. She suggested that such openness may give patients the confidence to ask providers for guidance on how to manage their disease.   “The main thing that I find most helpful for my patients is to explain the potential [adverse] effects, explain that there's something that we can do about them—that we can intervene. If they reach out to us sooner, we can help them more,” Donahue concluded. “I hope that the providers who are listening to this now can help to empower their patients to reach out and to ask for advice. That's the best thing that they can do to keep them on these medications longer. They can work well; we can show that in studies. But if we can't keep [patients] on the medications, then what are we doing?”

“With the turnover rates where they're at now, there's no way we can keep thinking how we did in the past—like, we have to. There's no doubt. We have to think differently,” Deborah Cline, DNP, RN, associate professor in the Department of Graduate Studies with Cizik School of Nursing at UTHealth Houston in Texas, told Jaime Weimer, MSN, RN, AGCNS-BS, AOCNS®, manager of oncology nursing practice at ONS, during a discussion about oncology nurse retention.  You can earn free NCPD contact hours after listening to this episode and completing the evaluation linked below.   Music Credit: “Fireflies and Stardust” by Kevin MacLeod  Licensed under Creative Commons by Attribution 3.0  Earn 1.0 contact hours of nursing continuing professional development (NCPD), which may be applied to the professional practice and performance ILNA categories, by listening to the full recording and completing an evaluation at myoutcomes.ons.org by December 29, 2025. The planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of NCPD by the American Nurses Credentialing Center's Commission on Accreditation.  Learning outcome: The learner will report an increase in knowledge related to nurse retention strategies.  Episode Notes  Complete this evaluation for free NCPD.  Oncology Nursing Podcast: Episode 231: Nurses Thrive in a Healthy Work Culture Episode 187: The Critical Need for Well-Being and Resiliency and How to Practice Episode 85: Nursing Resilience and Self-Care Aren't Optional  ONS Voice articles: Train and Retain: From Orientation to Leadership, Here Are the Strategies That Experienced Staff Developers Use American Rescue Plan Funds Will Reduce Burnout, Promote Mental Wellness Among Healthcare Workforce Biden-Harris Administration Invests $100 Million in Awards to Grow the Nursing Workforce Create Space Between Work and Life With These ONS Member-Tested Techniques  Clinical Oncology Nursing: Will You Leave or Stay?  ONS Nurse Well-Being Learning Library  ONS Symptom Interventions and Guidelines: Peripheral Neuropathy  The Journal of Excellence in Nursing Leadership: The Accreditation in Shared Governance Program (Robert Hess)  American Nurses Foundation Stress and Burnout Prevention Program  National Academy of Medicine Action Collaborative on Clinician Well-Being and Resilience  Would you like to hear more from Debbie and about the future of nurse retention? Check out her next presentation at ONS Congress® in April 2024.  To discuss the information in this episode with other oncology nurses, visit the ONS Communities.   To find resources for creating an ONS Podcast Club in your chapter or nursing community, visit the ONS Podcast Library.  To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org.  Highlights From Today's Episode  “When you look at the data, we have over 3 million nurses in the United States. Approximately, 1.7 million of those are in the hospitals, but unfortunately, the turnover rate has nearly doubled. Just since 2019, where it was about 15.9% nationally, we are over 27% since 2021.” TS 1:45  “The data actually shows that it's turnover in early-career nurses. When we're looking at that first five years of data and who's turning over, it's our nurses that are one to two years. Our patients are so complex. When you're looking at staff turnover that's early, we're going to have a huge problem getting to the point where we can keep some of the knowledge going, and when you lose them early, it's not good for nursing and oncology nursing in specific.” TS 3:05  “In May of this year, we learned that nursing enrollments for entry level baccalaureate programs are down for the first time in over a 20-year period. So, that is really concerning. So, enrollments are down. There's challenges getting clinical placements depending on where you are, not to mention that oncology clinical placements I think are even harder to come by. Some organizations feel very strongly that clinical placement in an oncology setting may not be appropriate for undergraduate students.” TS 6:06  “A lot of children don't understand what it is that a nurse does. When you ask them, ‘Oh, you give shots,' and that's your role. And so really helping kids at all ages—elementary, middle school, high school—talking to them about what nursing is, what it looks like on a day-to-day basis, the critical skills you need to the complexity of your workday, I think can really incite some younger children to understand, ‘Oh, nursing is an option for me.'” TS 8:47  “It's a challenge to put your head around. I could be a new grad doing this, and we all have this, you know, idealism that, ‘Oh, you have to have acute care inpatient first before you can do that,' but we can't, right? We can't sustain that model. So, how are we building our programs to ensure that ambulatory care nurses that happen to be new grads in oncology are getting a solid training program with stable preceptorship and a very structured program that can be individualized to their needs?” TS 14:12  “There's also the aging workforce. The oncology nurses that have started in oncology or transition to oncology at any point in time—they love it. … Anecdotally, we probably have some of the most experienced nurses in many of our organizations that are in oncology. Those nurses are also looking at retiring.” TS 17:38  “You have to have professional development opportunities. What educational opportunities? And if your organization doesn't have the funding for that, that's okay. You could promote education that might be free online or through Oncology Nursing Society. There are ways to bring your staff education that doesn't cost a lot of money, but many organizations do have an education team that may also be adding to those opportunities.” TS 20:13  “If you're in a unit that has a lot of vacancy rates, how often are you sharing with nursing staff, ‘Okay, I've done X amount of interviews this week, or we have these new nurses coming in to join us or nursing assistants, whatever role that may be coming to join us.'  What does that timeline look like? A lot of times I think we don't promote that transparency well enough. And I think establishing that communication with your team and increasing the level of trust and transparency is so vital.” TS 26:12  “My first organization to my second organization, I was still a stem cell transplant nurse, but the experience was different. So, we need to also trust ourselves that sometimes it's just not the right fit. And I don't think we do a good job as nursing organization and like as health care organizations supporting those types of transitions. And I think there's a lot of opportunity there.” TS 32:25  “Ensuring that you're not picking up so much overtime, you don't have time—the downtime to take care of yourself and take care of your family and spend time and figure out what feeds your soul. I think it's so, so important to figure out what that is for yourself. And sometimes it takes a lot of reflection and exploration to figure that out. But it's worth the time in the effort to do that.” TS 41:06  “A lot of times, it's easy to kind of get in this, ‘I'm just going to keep complaining, but I'm not going to do anything.' But we all need to be part of the solution to get us moving forward and to stabilize the nursing shortages that we have. And unfortunately, I don't think it's going away. I think we've got several more years that we're all going to have to purposely look for solutions and work on implementing solutions to help stabilize the workforce.” TS 44:27  “Your best resource, and I say it again, is your team, your team, your team, your team. Talk to each other. Help figure out solutions together that are going to work for your specific milieu.” TS 49:14 

The Mesothelioma Applied Research Foundation can help guide you through the selection of medical specialists and treatments including clinical trials. Our on-staff mesothelioma expert, Shannon Sinclair, RN, BSN, OCN, is available to speak with patients and their families to help guide them through their diagnosis and treatment options. She can be reached at shannon@curemeso.org or by phone at (703) 879-3821. Shannon is an oncology nurse with 14 years of experience working at a large cancer center in Ohio where she worked with a multidisciplinary team comprised of medical and radiation oncologists, surgeons, and other specialties involved in cancer care. Shannon also spent time working as an oncology clinical nurse educator for a large pharmaceutical company, where she educated providers at cancer centers and hospitals about clinical trial data, upcoming indications, immunotherapy, PARP inhibitors (a special type of a targeted cancer drug), mechanisms of action of various agents, potential adverse events, and side-effect management. Earlier in her career she was an oncology specialty pharmacy nurse educating patients, caregivers, nurses, and clinicians on oral oncolytics. She holds the Oncology Certified Nurse (OCN) certification and certification through the Oncology Nursing Society for chemotherapy, biotherapy, and immunotherapy.

While it may be an uncomfortable topic to bring up, sharing your sexual orientation and gender identity with your cancer team can help improve your overall care. As we've discussed many times on this program, communication is key to improving your experience and ensuring you're receiving the best and most tailored, care for you. Chastity Burrows Walters will discuss the challenges individuals face in disclosing their sexual orientation and gender identity with their care team and will provide tips on how to have these conversations. She will discuss the importance of finding a cancer care provider who is both knowledgeable and respectful. Through establishing this relationship of trust, your care team can make better recommendations for screenings, support groups, or follow-up care. Speaker: Chasity Burrows Walters, PhD, RN Bio: Chasity Burrows Walters is the Senior Director of Patient and Community Education at Memorial Sloan Kettering Cancer Center (MSK). In that role, she is responsible for the vision, leadership, and strategic planning of educational initiatives, focusing on health equity. A longstanding advocate for LGBTQ patients, she is the founder and Leadership Sponsor of MSK's LGBTQ Clinical Advisory Committee and a leader in MSK's LGBTQ+ Pride, MSK's Employee Resource Network. Dr. Walters is a member of multiple professional organizations, including the Oncology Nursing Society, the American Society of Clinical Oncology, Sigma, GLMA, and is a past Chair of the Cancer Patient Education Network. In addition to awards for her leadership during her academic career, Dr. Walters has been the recipient of the Oncology Nursing Society Excellence in Patient and Public Education Award as well as the Cancer Patient Education Network's Distinguished Service Award. Dr. Walters has presented and published on a range of topics related to the care of LGBTQ patients and teaches LGBTQ Public Health. --- Support this podcast: https://anchor.fm/aimatmelanoma/support

Is your “Wheel in Alignment”? Marsh shares wisdom from her 43 year journey in nursing including surgical, public health, home health, oncology, and hospice & palliative care with an emphasis on pain management culminating in “The Wellness Wheel”, which is going beyond being free from disease and allowing your health and wellness to permeate all the areas of your life. Hear more from Marsha on “The Wellness Wheel” at the THRIVE Transylvania Health & Wellness Expo September 24th from 10am-2pm at 153 W. Jordan Street in Brevard, NC.

Joanna Morales is a cancer rights attorney, author, speaker, and CEO of Triage Cancer, a national, nonprofit organization providing free education on practical and legal issues that may impact individuals coping with cancer and their caregivers, through events, materials, and resources.Ms. Morales has spent nearly thirty years working on behalf of individuals with cancer, including five as an Adjunct Professor of Law at Loyola Law School, teaching a seminar in Cancer Rights Law, and eight at the John Wayne Cancer Institute's Psychosocial Care Program and Positive Appearance Center. She has also taught a Community Advocacy Clinic, as an Adjunct Professor of Law at Wayne State University Law School.Ms. Morales co-authored the book, Cancer Rights Law, for the American Bar Association – the first and only book of its kind. In 2020, she wrote a chapter Cancer-Related Legal Issues, for the Oncology Nursing Society's book, Oncology Nurse Navigation: Delivering Patient-Centered Care Across the Continuum. In 2017, she wrote Preventing or Minimizing Financial Toxicity Across the Continuum of Cancer Care, a chapter for the Oncology Nursing Society's book, Cancer Survivorship: Transdisciplinary, Patient-Centered Approaches to the Season of Survival. In 2009, she also contributed to a book entitled, Work and Cancer Survivors. And, her work has appeared in a variety of other publications, such as Psycho-Oncology, Heal, Cure, Coping with Cancer, Women, and Ability Magazine.Ms. Morales has presented nearly one thousand educational seminars on employment, insurance, health care, and advocacy issues throughout the country for individuals diagnosed with cancer, caregivers, health care professionals, advocates, lawyers, employers, and the general public.In addition, she has served on numerous cancer community committees and boards, including as Chair of the Board of Directors for the California Division of the American Cancer Society, ZERO Prostate Cancer's Medical Advisory Board, the National Advisory Board of CancerForward, the Stupid Cancer Survivorship Advisory Council, and the Executive Committee of the American Bar Association's Breast Cancer Task Force.Ms. Morales has received several awards and recognition for her service to the cancer community and her work in the area of legislative advocacy, including the 2009 Susan G. Komen for the Cure® Public Policy Advocate of the Year and the 2015 Legacy Advocate Award from Stupid Cancer. In 2010, she was recognized by the Los Angeles Daily Journal as one of the Top 20 Attorneys in California Under the Age of 40.Ms. Morales earned a Bachelor of Arts in Political Science with an emphasis in International Relations from the University of California Los Angeles and a Juris Doctor from Loyola Law School Los Angeles.Joanna Morales can be reached at TriageCancer.org.***Follow the Greg Krino Show here...GregKrino.comYouTubeInstagramFacebookTwitterLinkedInIf you enjoyed the podcast, please leave a 5-star rating and friendly comment on your podcast app. It takes only a minute, and it really helps convince popular guests to join me.If you have comments or ideas for the show, please contact me at gregkrinoshow@gmail.com.

Looking to get more out of nursing than just a job? Joining a nursing professional organization is a great way to enrich your nursing life and have some fun along the way.  Being an active member of a professional organization expands your horizons. In this episode host Natalie D'Itri shares a summary of benefits from membership in a professional nursing organization.  Nursing specialty organizations mentioned in this episode: Oncology Nursing Society www.ons.org Emergency Nurses Association www.ena.org Hospice and Palliative Nurses Association www.advancingexpertcare.org American Association of Critical Care Nursing www.aacn.org American Psychiatric Nurses Association www.apna.org Association of Women's Health, Obstetric, and Neonatal Nursing  www.awhonn.org ----more---- Careerwise Nurse: Are you working your dream job or dreaming of another job?  Are you making sacrifices in your personal and professional life at your current job? Careerwise Nurse is meant for you! Tune in if you are launching your career, growing into your role, or seeking ways to thrive as a nurse!   Current and future student nurses - this is for you, too! The Careerwise Nurse podcast includes stories and tips from nurses for nurses.  Careerwise Nurse is an opportunity to connect with a coach, who is focused on your professional self-care and nursing career success. Let's talk about Nursing Life! Schedule a free call!  - https://calendly.com/natalie-ditri/careerwisenurse         ----more---- Follow and Connect!  If you have not had a chance, please FOLLOW the show  Give a 5-Star rating + written review!!  This helps the show grow and reach more nurses like you!!! Careerwise Nurse Engagement Call - https://calendly.com/natalie-ditri/careerwisenurse Connect with host and coach, Natalie D'Itri - belong@careerwisenurse.com Join the Facebook community - Careerwise Nurse Instagram @CareerwiseNurse LinkedIn https://www.linkedin.com/in/natalieditri/

Many skin cancer survivors develop high anxiety regarding sun exposure and being outside, especially during summer. How can active coping strategies and behavioral changes help patients address these concerns? In this conversation, we'll discuss the psychological impacts of UV exposure on patients and how you can continue to live life to the fullest while protecting yourself and those you love from harmful exposure. Guest: Kathleen M. Madden, MSN, FNP-BC, AOCNP®, APHN & Melissa Wilson, PA-C, MPAS Kathleen Madden, MSN, FNP-BC, AOCNP®, APHN is a Family Nurse Practitioner in the melanoma & cutaneous medical oncology group of the Laura and Isaac Perlmutter Clinical Cancer Center at NYU Langone Medical Center in New York City. Kathy's experience during the past two decades at NYU has included working primarily in adult medicine and oncology with a focus on skin cancers with melanoma; she also serves as a sub-investigator for all melanoma & cutaneous research protocols and select phase 1 protocol at the Clinical Cancer Center. Kathy lectures nationally in her area of expertise and has multiple publications in her specialty. She has also served as clinical adjunct faculty for students working toward their bachelor's and master of science in nursing. Kathy is also passionate about integrative healing arts and holds board certifications in Advanced Practice in Oncology and Holistic Nursing and additional certifications in Clinical Homeopathy, Clinical Aromatherapy, IGM® Practitioner and Instructor, Clinical Meditation, and Imagery. She is a member of the Oncology Nursing Society, ASCO, APSHO, ANA, American Holistic Nurses Association as well as other professional organizations. Kathy continues to pursue learning experiences that synthesize eastern and western modalities, ultimately enhancing and benefiting both personal and professional endeavors. --- Support this podcast: https://anchor.fm/aimatmelanoma/support

In This Episode, You Will Learn: Advice and helpful resources for cancer prevention. How to form healthy habits for a healthy lifestyle. Tips for night shift nurses, new grads, and nurses interested in non-bedside jobs. Resources + Links: Follow Becky on Instagram | @rstrn   Get involved at https://nurseshealthstudy.org/   Learn more about cancer prevention at https://www.aicr.org/   Check out these other organizations, studies, and resources: American Cancer Society: www.cancer.org for screening information Oncology Nursing Society: www.ons.org for navigator resources and core competencies!  Nurses Health Study: https://nurseshealthstudy.org/  Lots of publications from their data on the site. Here is a link to join the new study: https://www.nhs3.org/   Indeed.com also has some good resources for helping evaluate/thinking through next steps in finding a job you'll enjoy.   Check out these articles: Center for Disease Control and Prevention:  Night shift and cancer risk https://blogs.cdc.gov/niosh-science-blog/2021/04/27/nightshift-cancer/   Moving past fear, Donna Cardillo: https://donnacardillo.com/articles/movingpastfear/  Connect with us on Instagram | @lifeinscrubspodcast   Follow along with our personal Instagram pages too!   Connect with Kristen on Instagram | @thenursekristen  Connect with Maddi on Instagram | @nurse.maddi  Show Notes: How can we create and promote healthier lifestyles? This week we have a new guest joining us: Becky Trupp, an oncology nurse navigator from the Seville Cancer Screening and Prevention Center! With 32 years of experience under her belt, Becky will share her wisdom on cancer prevention and healthy living for nurses just like you. We'll cover what you need to know about cancer prevention so you can help keep yourself and your loved ones safe. Then, we'll go over useful tips for night shift nurses to look out for, as well as advice for those interested in getting involved in non-bedside jobs. We've got your key to a healthier future right here! 00:40 Meet Becky Trupp, an oncology nurse navigator from the Seville Cancer Screening and Prevention Center! 01:30 How did you get to where you are today? 04:20 Opening yourself up to new possibilities. 07:30 Where did you go after you were let go from your high risk job? 09:10 How have your experiences with past jobs helped you in the present? 10:15 What do you do at your center? 11:15 What do you think is most important for nurses to know about cancer prevention? 14:50 How does working the night shift affect nurses? 16:35 What are some resources you recommend for nurses? 18:10 What tips do you have for night shift nurses to take care of themselves? 20:55 Forming small habits to create big changes in your lifestyle. 24:15 How can someone get involved in more non-bedside jobs? 27:20 Would you recommend a new grad have experience before going into a nurse navigation position? 31:25 Where can people look for more information on cancer prevention?

To receive up to 1.5 ANCC contact hours, please complete the evaluation and request form here: https://ce.ceconcepts.com/ONS2022This symposium will explore the latest ovarian cancer guideline recommendations and recent evidence for PARP inhibitors in treatment and maintenance settings. The nurse's role in facilitating access to quality care for those with disparities, the unique toxicity profiles of PARP inhibitors, and how to mitigate, anticipate, and manage toxicities that may arise will also be discussed. Attendees will interact with the expert faculty through patient cases with audience response questions incorporated throughout.Supported through an independent educational grant from GlaxoSmithKline.Presented by Creative Educational Concepts, LLC.

Chaitenya “Chat” Razdan is the Founder and CEO of Care+Wear, a healthwear company changing the way the world looks at and feels about healthcare. Chat left his career as an investment banker at Goldman Sachs to launch Care+Wear, creating products that bridge fashion and function. Care+Wear is focused on helping those inside and outside of the hospital feel more like people. Named one of the 100 most intriguing entrepreneurs by Goldman Sachs, Chat has been featured as one of the Rising Stars by Becker's Healthcare and named as one of the Top 40 under 40 Minority Healthcare Leaders by the National Minority Quality Forum. He has spoken at industry conferences including the Aspen Ideas Festival, Association for Vascular Access and Oncology Nursing Society. Care+Wear has been featured in The New York Times, Forbes, Fast Company, Huffington Post, ABC, NPR, and more. Chat is a proud alumnus of the University of Virginia and received his MBA from the University of Chicago Booth School of Business. He serves as Co-Chair of his reunions for UVA and the Advisory Board for the McIntire School of Commerce, Co-Chair of the Alumni New Venture Challenge for Chicago Booth's New York chapter, is also involved with Ronald McDonald House of New York, the NYU Langone Patient Research Advisory Council, the Association for Vascular Access, and the Association for Vascular Access Beyond Acute Care Significant Interest Group, among others. Get in touch with Chat: Instagram: https://www.instagram.com/careandwear/ Facebook: https://www.facebook.com/careandwear Twitter: https://twitter.com/careandwear LinkedIn: https://www.linkedin.com/in/chaitenyarazdan/ Book your free Strategy Flow call today! https://www.outfieldleadership.com/#call Purchase Dave's book The Self-Evolved Leader here- https://www.amazon.com/Self-evolved-Leader-Elevate-Develop-Refuses/dp/1626346801 Get in touch with Dave: Website: https://www.davemckeown.com/ Twitter: https://twitter.com/davemckeown Instagram: https://www.instagram.com/davemckeown1/?hl=en

In this episode Wellness Within Founder Patti Brown, MS LMFT is joined by honored guest, Anne Katz, PhD, RN, FAAN to discuss Cancer and Sexuality.  Dr. Katz addresses the need for oncologists to break the silence on the topic of sexuality with their patients, how survivors and their partners can navigate vulnerable conversations about sexuality, and also how to find body acceptance after physical changes from cancer and its treatments. Dr. Anne Katz is a certified sexuality counselor and Clinical Nurse Specialist in Manitoba. She is the editor of the Oncology Nursing Forum, the premier research journal of the Oncology Nursing Society. She has educated thousands of cancer survivors and health care providers about cancer, sexuality, and survivorship. She is the author of going on 16 books for health care providers and readers on the topics of illness, sexuality and cancer survivorship. "My professional life is focused on providing information, education and counseling to people with cancer and their partners about sexual changes that can occur during and after treatment.But there is another important aspect to this work; I want every person with cancer to be able to have a discussion about sexuality with their health care providers. And so I travel around the world, teaching health care providers to ask their patients about this important part of quality of life."Learn more about Dr. Katz, her books, podcast and her services at https://www.drannekatz.com/. Tune into her podcast, Sexually Speaking with Dr. Anne Katz, on popular podcast platforms or on her website.This podcast is sponsored in part by Koinonia Family Services, Consolidated Communications, and Merchants Bank of Commerce. This podcast is offered freely to ensure everyone has access to these practices and conversations offered by Wellness Within Cancer Support Services. If you feel inspired to donate to support Wellness Within offerings, please visit www.wellnesswithin.org/giveSupport the show (https://www.paypal.com/donate?hosted_button_id=4GNQH4LSJ6EKY)

Kris LeFebvre MSN, RN, NPD-BC, AOCN® works as an Oncology Clinical Specialist, at the national office of the Oncology Nursing Society. She works on a variety of educational and collaborative projects, including the ASCO/ONS Chemotherapy Administration Safety Standards, the Oral Chemotherapy Education Sheets, ONS Chemotherapy and Immunotherapy Guidelines, and many ONS safe handling, international, and leadership initiatives. Kris has been an oncology nurse for more than 30 years, working clinically in the roles of staff nurse, nurse manager, and clinical nurse specialist in oncology and bone marrow transplant. She lives in western Massachusetts and began working at ONS in 2004.Connect with Kris: klefebvre@ons.orgConnect with Oncology Nursing Society: www.ons.org-----------------------------------------------------------------------------1.  Click the link to learn more about the Nurse Wellness Mentorship2. Download your FREE Mindfulness E-Book at stressblueprint.com/353. Follow the Nurse Wellness Podcast on Facebook and Instagram4. Email Nurse Wellness Podcast at hello@stressblueprint.com5. Background music produced by DNMbeats

Prostate cancer does not only affect the patient. It also affects his spouse or partner. For today's episode, we are excited to bring Dr. Anne Katz onto the show! Dr. Katz has dedicated much of her professional life to educating and counseling couples, helping them support each other through the journey of prostate cancer, and thrive as a couple.   Dr. Anne Katz is a widely respected and internationally recognized authority on human sexuality and how it affects those living with cancer. Dr. Katz is a certified sexuality counselor at CancerCare Manitoba and clinical nurse specialist at the Manitoba Prostate Centre. She is the editor of the Oncology Nursing Forum, which is the premier research journal of the Oncology Nursing Society. She got inducted into the American Academy of Nursing in 2014. She has educated healthcare providers and people with cancer about cancer, sexuality, and survivorship around the world. She is an avid blogger for the ASCO Connection, a professional networking site for the American Society of Clinical Oncology's worldwide oncology community.  She is the author of 14 books for healthcare providers and healthcare consumers on illness and sexuality and cancer survivorship. The books she has written include Prostate Cancer and the Man You Love, written for every individual who has loved, supported, and cared for a partner or spouse with prostate cancer.  In September of 2020, she launched her podcast, Sexually Speaking Podcast, intended to inform and educate. Dr. Katz features guests talking about a wide range of topics related to sexuality. Be sure to join us today to learn what Dr. Katz has to share about supporting someone you love with prostate cancer. Disclaimer: The Prostate Health Podcast is for informational purposes only. Nothing in this podcast should be construed as medical advice. By listening to the podcast, no physician-patient relationship has been formed. For more information and counseling, you must contact your personal physician or urologist with questions about your unique situation. Show highlights: Dr. Katz explains what motivated her to follow the path she has chosen to get to where she is today. Dr. Katz explains why prostate cancer often gets referred to as a couple's disease. The potential changes that can occur in a relationship as a result of prostate cancer. Dr. Katz talks about the advice she initially offers the partner or spouse after learning about their partner's prostate cancer. Dr. Katz explains how a partner can best support their man with prostate cancer. Dr. Katz gives some tips for men with cancer to support their partners. Dr. Katz describes how she advises the partner or spouse in dealing with their own distress that comes with the prostate cancer journey. Dr. Katz shares what she has found to be the key behaviors to being a happy couple. Dr. Katz talks about the books she has written. Links and resources: Follow Dr. Pohlman on Twitter and Instagram - @gpohlmanmd  Get your free What To Expect Guide (or find the link here, on our podcast website)   Join our Facebook group  Follow Dr. Pohlman on Twitter and Instagram  Go to the Prostate Health Academy to sign up for the wait-list for our bonus video content.  You can access Dr. Pohlman's free mini webinar, where he discusses his top three tips to promote men's prostate health, longevity, and quality of life here. Dr. Anne Katz's website Dr. Anne Katz's book website Get your copy of Dr. Katz's book, Prostate Cancer and the Man You Love from any online bookseller, published by Roman and Littlefield.   

In this episode, Co-Founders of Survivorship Solutions, Jillian Schmitt and Kristin Carroll, talk about Cancer Survivorship and the need for Caner Rehab Education. Today, Jillian and Kristin talk about the prevalence of cancer, the importance of competency in cancer rehabilitation for all rehab clinicians, and compiling educational courses from leaders in the field. When should cancer rehabilitation start? Jillian and Kristin tell us that learning is not enough, hear about the value of mentorship, and Jillian and Kristin’s community of clinicians, all on today’s episode of The Healthy, Wealthy & Smart Podcast.   Key Takeaways “Cancer is not just one type of cancer. Cancer is not just what you’re seeing on the outside, there are physical changes on the inside as well.” “One thing that physical therapists have to keep in mind is that 100% of physical therapists, at some point in their physical therapy career, will see someone with cancer.” “If you want to stay on the bus, get competent and elevate your skillset to everything, not just cancer rehabilitation, but add that as another skill in your pocket.” “If you are a clinician or a therapist, it really is your ethical responsibility to take care of every patient that comes through the door, regardless of what their past medical history is. If you are not confident and competent in taking care of oncology patients, get that way. There’s a solution for you. Educate yourself, feel comfortable, feel confident, take care of your patient the way you should.” “For administrators and leadership teams, you really want to know that your team can take care of this population. If you do not have something in place that is ensuring that your clinicians and rehabilitation teams are really competent at taking care of these patients, you need to get that way, and you need to get that way pretty quick because the regulations and requirements from the very top levels are requiring that you do that.” “If your oncologist is not talking to you about function and what’s happening to you during your cancer journey and how that is going to be mitigated, or how you’re going to have a rehabilitation therapist of some sort as part of your team, ask for it. It needs to have this bottom-up push as well.” “Think big, be brave, and just go for it.” “Keep being a sponge. Keep learning. Don’t be afraid to try new things. When you’re starting to get burned out, try something else. Keep learning and keep growing, and eventually you’re going to find something that just wows you and really makes you change not only your career, but your personal growth as well.”   More about Kristin Kristin has been in clinical care and leadership roles within the Boston and Hartford healthcare systems for over 30 years. For over a decade she has focused on elevating her oncology specific practice with Klose coursework in lymphedema, oncology and breast cancer rehabilitation specialty courses through Julia Osborne and the American Physical Therapy Association (APTA); Academy of Oncologic Physical Therapy, and earned completion certificates in Chemotherapy/ Biotherapy Agents and Radiation Therapy from the Oncology Nursing Society. She is planning to sit for the 2021 Oncologic Certified Specialist Examination. Kristin has been a mentor, clinical coordinator, and educator at both the system and collegiate level. She continues to serve as an educator through her role as an instructor within Survivorship Solutions ’clinical education course: Core Competencies in Interdisciplinary Cancer Rehabilitation, contributing to guest podcasts on Breast Friends Cancer Support Radio, Mama Bear Cancer Support Radio Talk Show, and The OncoPT Podcast, contributing to Alene Nitzky’ s book “Navigating the C: A Nurse Charts the Course for Cancer Survivorship Care”, and as invited speaker at the International Breast Cancer and Wellness Summit, and the American Congress of Rehabilitation Medicine National Conference 2020. She actively supports and is involved in the oncology community as a member of the American Congress of Rehabilitation Medicine Integrative Cancer Rehabilitation Task Force, Connecticut Lymphedema Consortium, local and national chapters of the American Physical Therapy Association (APTA); APTA Academy of Oncologic Physical Therapy, Hospice and Palliative Care Special Interest Group, and serves on the board of the APTA Connecticut Oncology Special Interest Group as Program Coordinator. Kristin received her Bachelor of Science in Physical Therapy from Northeastern University. More About Jillian: Jillian is a licensed physical therapist with over 20 years of experience in patient care, clinic development, management, and consulting within the fields of oncology, orthopedics, pediatrics, ergonomics, and corporate health. She studied biochemistry and business management at the University of Texas at Austin, and received a Bachelor of Science degree in Healthcare Sciences and a Master's degree in Physical Therapy from the University of Texas Medical Branch in 2001. Much of Jillian's early career focused on orthopedic and pediatric physical therapy intervention, specializing in complex, limb-salvage rehabilitation programs, spinal dysfunction, and sports medicine. Later, she turned her attention to program development, clinic start-ups, and management within the corporate healthcare industry. For the past six years, she has consulted in the implementation and optimization of survivorship services and cancer rehabilitation programs within national healthcare organizations. Jillian maintains professional licensure in physical therapy and participates in continuing education programs and certifications within oncology and other specialties. She serves as a contributing and presenting team member for the American Congress of Rehabilitative Medicine (ACRM)'s Integrative Cancer Rehab Taskforce and is a member of both the Education Section and Oncology Section of the American Physical Therapy Association (APTA). She also participates as a member of the Hospice and Palliative Care Special Interest Group (SIG). Jillian regularly contributes to podcasts, journals, and other professional publications related to oncology, healthcare, and business, and she participates and contributes regularly within the entrepreneur and small-business community of the Chicago-land area, including SCORE mentorship and women-led business groups. In 2016, Kristin and Jillian founded Survivorship Solutions, LLC., an education and consultancy firm dedicated to supporting clinicians and healthcare organizations in implementing high-quality cancer rehabilitation and survivorship services. The company collaborates with national and global experts in oncology, survivorship, and rehabilitation to grow team safety and competencies in oncology knowledge and evidence-based care.     Suggested Keywords Physiotherapy, Learning, Cancer, Research, PT, Health, Therapy, Oncology, Survivorship, Healthcare, Education, Training,   Recommended viewing https://vimeo.com/485402119 https://survivorshipsolutions.com/p/core-competencies-in-interdisciplinary-cancer-rehabilitation-2-0   To learn more, follow Jillian and Kristin at: Website:          https://survivorshipsolutions.com Vimeo:             https://vimeo.com/survivorshipsolutions Facebook:       Survivorship Solutions Instagram:       @survivorshipsolutions Twitter:            @survivorshipsol                         @KCarrollPT                         @JSchmittPT LinkedIn:         Kristin Carroll                         Jillian Schmitt                         Survivorship Solutions LLC NetHealth Webinar:  Rehab Therapy Outpatient Services 101: How to Expand into the Home or Assisted Living Facility. Subscribe to Healthy, Wealthy & Smart: Website: https://podcast.healthywealthysmart.com Apple Podcasts:        https://podcasts.apple.com/us/podcast/healthy-wealthy-smart/id532717264 Spotify:                       https://open.spotify.com/show/6ELmKwE4mSZXBB8TiQvp73 SoundCloud: https://soundcloud.com/healthywealthysmart Stitcher:  https://www.stitcher.com/show/healthy-wealthy-smart iHeart Radio: https://www.iheart.com/podcast/263-healthy-wealthy-smart-27628927   Read the Full Transcript: Speaker 1 (00:00): Hey, Kristin and Jillian, welcome to the podcast. I'm so happy to have you guys on Speaker 2 (00:07): Or happy to be here. Speaker 3 (00:09): Thank you so much for having us on today. Speaker 1 (00:11): So today we're going to talk about cancer, survivorship. This is something that I've spoken to, one of your colleagues, Dr. Nicole Stout with, but before we get talking about that, what I would love to know is how the two of you came together to create survivorship solutions, the how, and the why behind it. Speaker 2 (00:31): So, Kristen and I knew each other before we started the company together for a couple of years, we, we previously worked for another organization and had similar roles and that was to implement cancer rehabilitation, service lines within healthcare systems. And Kristen and I really connected during that time. And we really enjoyed working with each other. We valued a lot of the same things. And so once we left that situation or once that situation of our, our, you know, once that's working together no longer happened for that particular company, we decided that we were great together and that we would we needed to continue the work. And so we started survivorship solutions together Speaker 3 (01:21): And Julia and I are both physical therapists and I have a special, I've been working with oncology patients for over 12 years. And even though we're both PTs, we both kind of had different soap boxes and what we were so passionate about. And Jillian has a love and just a savvy for business and growth. And you know, I just love to educate and things like that. So together, you know, just our, our strengths and our passions just forged us forward to create this, this company to, to continue to help healthcare organizations, but also individual commissions that, that really just needed to get more information on how to take care of people with cancer. Speaker 1 (01:59): Yeah. And that was my next question is where, where was the gap that, what was the gap that you guys saw that you were like, Hey, if we can put our heads together and create this, we're really going to help fill that gap? Speaker 2 (02:11): Right. Well, you know, for me personally, it was I was not a cancer rehabilitation therapist for most of my, my clinical career. I was in orthopedics and I th the opportunity to begin working in cancer rehabilitation actually came about it was pretty unexpected. I received a phone call from a very good friend of mine and also therapists I would school with. And I've been in practice for 15 years and she said, you know, I think that this would be a really good opportunity for you, you know, you, you've married sort of this business. And I, because I had opened clinics and I had done a lot of the, the business part of it. And but I really loved clinical practice. And I also had a very personal situation occurring in my life, or one of my loved ones was experiencing the cancer journey and really having a lot of issues and a lot of problems that I was really familiar with. But I, you know, like weakness and numbness and things like the things that physical symptoms, but I was just kind of watching through this lens and like, all right, well, that's like what I do every day, but why isn't somebody helping him? So it was all these three things that kind of came together and took me out of my orthopedic world pretty quickly and thrust me into the cancer rehabilitation world, which I had thought, I mean, admittedly been very naive of until that happened. Speaker 3 (03:43): Yeah. And I was working in an outpatient center and had surgeons come to ask if I would become competent to learn how to take care of breast cancer patients. Cause they were breast cancer surgeons. So I went to Olympia DEMA course and I learned all about lymphedema. And then I came back and I saw a breast cancer patient and I was all excited to use my new education that I just learned and she didn't have lymphedema, but I was like, Oh my God, what do I do with her? I mean, I learned all about lymphedema isn't that cancer rehab isn't. And so Julie and I learned quickly that in order to really become competent, to take care of people with cancer, you have to travel around the country at your conferences and online and, and do all sorts of things to get there. But a lot of it was just disease specific, like just breast cancer. So how do you learn how to take care of everybody that has all different kinds of cancers and all the different problems? So we felt that it really was our ethical responsibility as we were working with healthcare organizations to make sure that if we were going to implement a program, we had to make sure the team really was confident and competent to do that. So how we created education to go along with that implementation. Speaker 1 (04:54): Yeah. Excellent. And, and I will say that people who, like, I know people who've been diagnosed with cancer and as of yet only like two of them have gone to physical therapy. One of which was because I said, you have to go to physical therapy, she had a double mastectomy. And I said, tell your doctor that you want to go to PT afterwards. And she was like, but the doctor gave me this list of exercises. And I said, no, no, no, no, no. Tell your doctor, you want to go to see a physical therapist after this and, and sh afterwards she was like, yeah, I I definitely needed a PT. And so I think the issue here, and we'll get into that, we'll get into this conversation in a little bit, but you know, the issue here is that cancer is not just one type of cancer. Cancer is not just a, what you're seeing on the outside, but there are physical changes on the inside as well. And that's where being a knowledgeable physical therapist on, on the rehab of people diagnosed with cancer is so important, but let's talk about cancer in particular. So cancer itself can affect anyone true or false. That's absolutely right. Yeah, definitely. And so let's talk a little bit about the, this sort of prevalence of cancer and what that means for us right now, Speaker 3 (06:31): Almost 17 million cancer survivors in the country. And so that is all different ages, you know, doesn't matter which sex, all different kinds of cancers, definitely cancer is not discriminant. And so you talk about the gap in care. And Andrew Chevelle is, is kind of huge in our cancer rehab world and does research. And you know, she talks about the 83% of general cancer survivors have problems that really require rehabilitation and take it to the other end where women sorry, excuse me, general cancer metastatic or stage four, they have up to 92% of problems. So obviously somebody that has a chronic cancer condition is going to have more and more problems because they are receiving more and more treatments. And so the percentage of people that actually get rehabilitation is only about 30% according to, to her study. So that's, you know, that's a huge gap in care wizards. Speaker 3 (07:25): It's 83% of general cancer survivors or the 92% of our metastatic breast cancer patients. That's a huge gap with 30%. So when we're looking at that, if you're young and you're diagnosed with cancer and you have treatment, you're going to grow up to have perhaps problems, you know, as you get older. And so, you know, these people are inside our clinics already. And sometimes it's a little tiny past medical history. That's checked, you know, on their, on their form and we see cancer, but yet we're a little bit afraid sometimes to ask a little bit about what that is. And, and even I do that when I'm in a private room with my cancer patients that I'm treating them, I have no problem talking about what they went through, but on an open clinic. And I see that little word cancer, sometimes I, I will say, Oh, well, you had cancer. What kind did you have? And you know, but we really have to have these conversations. What kind of cancer did you have? What kind of treatment did you have because it really can impact the treatment that you are providing your patient, whether they're a pediatric patient, you know, an inpatient and outpatient adult really doesn't matter what the setting is. It really could depend on what your care plan is going to be. Speaker 1 (08:41): And Karen, you, you had mentioned that you said you asked, can anybody get cancer and can this affect everybody? And absolutely. And I think what's, what's really interesting is that healthcare professionals, you, myself Speaker 2 (08:56): Included, we don't necessarily automatically think about like the, the functional consequences of having cancer, even though we see it. We're so we have this new normal instilled in us that we sort of expect cancer patients to not have normal function or not be doing well. And it just really to be part of what the expectation is once you get that diagnosis. And even me, even somebody that has worked in therapy for a long time and having a person very close to me, experiencing physical symptoms, I still, it was almost like a, it was just sort of like an out of, Oh, you know, like I didn't really make sense to me why he wasn't getting it, but it wasn't sort of this, well, this is a person that needs to have therapy. That connection wasn't, wasn't quite there yet. And I think that that's true for a lot of clinicians. Speaker 2 (09:49): They say, well, we, we don't see cancer patients, but but w w what Christina likes to say, well, yes, you actually, you have, and you do you see them probably every day on your schedule, there's such a high percentage of people that cancer at this point, that if you're seeing any population in ortho population or a neuro population or whatever in your clinic, you have seen patients that have either current or a previous diagnosis of cancer. And so you are, these patients are coming into our clinics already, and people are just not really making that connection. Speaker 1 (10:23): Yeah. I remember when I spoke to Nicole, she said, one thing that all physical therapists have to keep in mind is a hundred percent of physical therapists in, at some point in their physical therapy career will see someone with Speaker 2 (10:36): Absolutely, absolutely. Probably this week. Yeah. And like, you know, it's, it's not, it's not when, or, or it's, I mean, like it's very, very soon because patients also don't necessarily think about the fact that they have a cancer diagnosis and it's something that they really need to kind of put, put front and center when they are going to rehab. So maybe they've had a knee replacement or they've had some other traditional rehabilitation problem, like a BA like back pain or whatever they go to PT for. And they had that pesky, you know, cancer diagnosis 10 years ago that colorectal cancer, but they, they got it and they got the third, but so they don't really, but you know what, those things that happened 10 years ago with that diagnosis and the medications that that patient had and the treatments that that patient had are actually going to impact the way that they heal in, in physical therapy. And so I think the patient doesn't understand the significance of it. And then the clinician doesn't really understand the significance of it. And it makes a huge impact in how well that patient is gonna, you know, do and how, and in the course of their therapy, it really should kind of direct the course of their therapy and and predict how well they're going to be able to, you know, certain, certain things that should be in therapy and certain things that should really not be done in therapy should be based on that. Speaker 1 (11:57): And something that as you're saying, all of this, that kind of struck me is that in physical therapy, you know, we are expected to have the competency to treat people with a total knee replacement, low back pain post-stroke Ms. But you guys have traveled around the country. You've spoken to many physical therapists, is that clinical competency in cancer rehab there amongst the physical therapy profession. And this is a silly question, but is it essential? Speaker 3 (12:35): I do. I think it was definitely not there. I mean, there are therapists that are very skilled at providing lymphedema treatments, and there are therapists that are very skilled in targeting certain kinds of breast cancer. But I think one of the things that we think, what I think about is that the things that people going through cancer treatment, it's kind of like an anticipated decline, right? Like we kind of know that they're going to feel like crap when they're going through chemotherapy. And I think that maybe, and I had this assumption that once their chemotherapy is over, they're going to be fine. And I think a lot of the providers think that as well, we kind of know that they're not going to do well during treatment, but I don't think that a lot of people know is that they don't do well even after treatment and that six months and years later, they have these effects. Speaker 3 (13:24): And because there are one in eight women that get breast cancer, and there are so many men that get prostate and other lung cancers are, are breast cancer women, and are prostate men have to take medications sometimes for five and 10 years, that affects their musculoskeletal system that affects every ortho therapist. If they're treating these people that are in their clinics. So there may be a general awareness, but I think there is kind of pick and choose, like you make it a lung cancer patients that you're treating for weakness. You don't have to treat weakness, you don't to treat balance issues, but you may not really understand what the chemo regimen did to the patient, why they're having those. So I think explain the why around it helps to decrease the fear that some therapists have of treating, because I sure was afraid when I saw my frail bald patients walking in, I was really afraid I was going to hurt them. And I didn't feel safe to take care of them because I had one month of DEMA course, and I wasn't. So we kind of wing it, right. Because there's not really many resources out there. Right, right. Speaker 2 (14:36): Back into my schoolwork and looked and to see what oncology criteria like curriculum that we had gone through when I was a student. And yeah, I mean, it was so minimal. It was less than a week was one core, like within one class that wasn't oncology focused. It was, I mean, the amount of information that clinicians were getting in school and professional programs was very, very minimal. And of course that's more than 20 years ago when I was in school. But even now even now I would say that there was a huge percentage of of clinicians that take our course who are new grads. They just got out of school. So we know, and we've communicated with them. Talk to them. This is not in their curriculum. They are not learning this in school. Otherwise they would not be seeking out some of this information that they know is really important anyway. And that's physical therapists, occupational therapists, anybody that's in allied health or are seeing patients really needs that they need to have this foundational, basic knowledge that makes them safe and makes them competent to care for these patients. And so it is a little, I I'm sure the education, maybe at some point we'll catch up, but it hasn't yet. Speaker 1 (15:56): Yeah. And, and I'm sure it also depends on what's on the MPTE, but that's a whole other thing and let's, we won't get into that, but we know that certainly exists when it comes to educational curriculum in schools. Yes. At any rate I digress. Let's talk about, let's talk about when should rehab physical therapy, occupational therapy start. So someone is diagnosed with cancer. When do they start their rehab? Speaker 3 (16:27): The rehabilitation starts at diagnosis and that's when the American cancer society. And so many of our, our industry regulators recommend that it started and it start from diagnosis all the way from end of life or end of care. And, you know, we compare this to kind of our other service lines, but, you know, somebody is having a knee replacement they're coming in for prehab, right. They're coming in for education, they're coming in for strengthening before they do that. And it's, it's no different for a patient with cancer. They need to be armed with what they are going to go through. Not only the education to help decrease their fear, but also the problems that they are going to incur, understanding that we have the skillset and the tools to be able to support them throughout that journey. And I think the other thing that rehab teams don't realize is that general clinicians that don't have specialties really can treat the scope of most of the impairments that people have. Just like we all can you know, balance and numbness and tingling and strength issues and fatigue, and just, you know, the list goes on and on, but if you have a pelvic health issue or if you have lymphedema, then we triaged to our, to our specialists Speaker 2 (17:35): And, and best practice really dictates that when you're going to begin any type of a treatment or any type of incur, any type of or undergo any type of surgery or anything like that, it's really to establish a baseline. And in cancer, there's really, it's, it's very important to establish a baseline because we know pretty, pretty well that cancer treatments are going to cause problems. They're going to exacerbate existing problems. And so if we can add diagnosis, capture what that baseline is for that patient and monitor and survey that patient and make sure that that patient is not there, that their existing, their preconditions or existing deficits or impairments are not getting worse or that new ones are not popping up. That really is best practice because we know that if we can see something pop up, you know, and catch it immediately, it's going to be a lot easier to take care of and to recover from or to prevent even then, if it's something that we don't, you know, that we don't look for until after treatment is over, maybe, you know, the patient is having a lot of functional problems that are really obvious. Speaker 2 (18:50): If you just wait until then it's going to be a lot harder to intervene and it's going to, I mean, and this is it's gonna be a lot more expensive. I mean, something that may take just an education and maybe one visit and rehabilitation from the very onset and the very beginning even something, you know, just as you're going to have this, you're going to have a lumpectomy you're going to guard you. You know, let's make sure that when this happens, you're going to continue to do range of motion within a certain, you know, limitation, but that the patient knows that that can later prevent like three months of a frozen shoulder. Right? I mean, like we know that this, these things happen all the time and it's easy to just kind of get in there from the beginning. So best practice is, is at the very beginning at diagnosis, patients should definitely be at least screened for impairments and informed that rehabilitation is part of their medical care. They should expect it, their patient should walk in knowing that rehabilitation is part of their medical team. Yeah, absolutely. Speaker 3 (19:52): And this is, and this is something that Nicole Stout talks a lot about in her research has called the process perspective surveillance model. And that is, you know, screening patients before each intervention. So we know kind of what we call each medical touch point. So whether they're having surgery or chemotherapy or radiation really being screened before each of those interventions. So like Jillian said, we can kind of pick up on those impairments when they're acute in nature, that's really important. Speaker 1 (20:19): And so let's talk about cancer rehabilitation education. I think we've already established that physical therapists do not get an adequate amount of cancer rehabilitation education in school, and you may not get it on the job either, depending on where you work. So couple that with millions and millions of people getting diagnosed with cancer every year rehab should start at the point of diagnosis. So let's talk about the education around it, because if that is the case, and now it is recommended rehab start at the time of diagnosis. And there are tons of PTs in this country and not many know how to deal with this. How do we educate physical therapists in a robust manner so they can help with these patients? Speaker 2 (21:15): Well, I think that things are kind of catching up here. It's been established that cancer rehabilitation is important and it needs to be part of cancer patients cancer care. And we have national regulatory agencies and different sort of top level drivers that are encouraging and really requiring organizations to provide cancer rehabilitation. So we have a lot of these companies that are starting to recognize, all right, are people that are in house already need to be doing this. And then from the clinician's perspective. And, and I can say this as a, as a physical therapist, if, if my boss had come to me in my outpatient clinic and said, okay, we're going to have a bunch of oncology patients come in the doors now. Because there's these guidelines and we're going to see this influx of patients and you guys are gonna be treating these patients. Speaker 2 (22:15): I would have been like, okay, like I would have been really nervous about it. And so we, we still sort of were getting that response as organizations are starting to implement some of these policies that are requiring that their organizations provide these services. So we're also getting this sort of searching from these clinicians, like, all right, I'm going to see cancer patients. And when I go online, I see like a billion, different CU courses for different types of, I mean, I can be different specialists in this or a specialist in that, or I can take this or I can take that. What I really want to know is how can I be safe to see these patients coming through the door. I don't, but maybe cancer is not there. And you know, what, what they're interested in, they don't want to specialize in it. Speaker 2 (23:03): That's fine. And so they don't want to spend thousands of dollars on specialties and weekends, but they do want to be safe and they want to know. And so Chris and I kind of came at it from that perspective, like, all right, we're gonna, we're gonna say, we're going to get more referrals in your clinics because of these guidelines, because it's the right thing to do because research says that cancer patients need it. But what's really important to us is that your clinicians feel competent. They feel safe. How can we create the education that your, your clinicians are gonna feel like they can have anybody land on their schedule and that's going to be fine because that's going to make them feel comfortable. And what that's going to do is going to make their bosses feel comfortable there. The leadership is going to know that their entire Rhea team has a competency and anybody can kind of come through there and that their service is going to be very similar from facility and location location. Speaker 2 (23:48): So we, that's kind of where we started with. We weren't, we didn't, we didn't want to make a course that was going to make somebody a specialist. Those are out there and they're awesome. And we work with all those people that make those courses. So we know they're awesome. We wanted to create something that was respectful of somebody's time and their money, and, and really want to just pull the most excellent parts of all those specialties into one spot so that a therapist could go through it and be pretty confident in their leadership can be pretty confident that they were that they were gonna be able to take care of these patients as they come through the doors. Speaker 3 (24:23): Yeah, Kristen, and then I, I was live and then I was living in the cancer rehabilitation world. So I knew a lot of the experts and the leaders in the field from just attending their courses and conferences like Nicole, Nicole Stout, and Julia Osborne. And, you know, just all of these amazing people that really aligned with the same mission and vision that Jillian and I both had to spread this education. And, but what was missing was a comprehensive online platform. And, you know, I I'm sitting for the specialty exam in February, but I'm an expert in certain things, but I certainly not the expert on everything. And so Joanie and I said, you know, when we're learning, we want to learn from our role models, right? Our peers and our colleagues who respect in the field. So we went out and we asked them, you know, will you help us create this education? Speaker 3 (25:18): And they all said, absolutely it's really important. And why it's important is because we have to get it in the hands of people quickly. I, it took me 12 years to kind of get all this information. We don't have that kind of time because we have almost 17 million people that need this care right now. And these patients are in the clinics and, and they need it. You know, they're, they're just people that want to do marathons and, you know, raise their children and go to school and do all the things that everybody else does. So how do we get it into the hands of people? So we went out and they created this, this education, and then we went and got it approved recently for continuing education credits. So it really is an amazing compilation of education that spreads a blanket over all different kinds of cancer, disease types and all the impairments. But it isn't just for somebody that wants to be competent and confident. Cause I went through it myself and I learned a lot of information and I've been doing this for over 12 years. So it really is also for clinicians that are interested in cancer rehabilitation that work in cancer rehabilitation, but are also experts because they will learn about a lot of things that there are no courses for like pharmacology. There are no courses for pharmacology, right. They're out there right now for to learn from Speaker 2 (26:39): It's really for the whole team. Yeah. And so when, so let's Speaker 1 (26:44): As a physical therapist I go through, through this chorus, I'm confident, I'm competent. And is it like, okay, thanks. I guess I'm, I'm, I'm good now. I don't need anything else. So what happens after this sort of ed, you have this experience with you guys and you're, you know, relatively confident and competent is, is that where the learning ends? Speaker 2 (27:12): No, I, I, I really love that you asked that question actually, because this is what I, this is my soap box. You know, we all, all of our presenters for our course, they all have their soap boxes. They're all specialists about what they think is the most important. That's why our education is awesome. We, you know, we went to the specialist, we said, give us 30 minutes, you know, or, or whatever that you think is the most important part of your specialty that you think all general people should know, and then they bring it in and that's, what's in the core. So you kind of get the best of everything and what the specialist actually think the general therapists really need to know about certain things. But we did recognize absolutely that once you have, this is acumen or you, this information about, you know, cancer rehabilitation and you have got to be able to communicate with others that have the same information that, that are there in the same world. Speaker 2 (28:02): Because even though there are going to be a lot of patients that are starting to come in in the future right now, it's a little bit of a small world. It's kind of a, a small world in regards to who is in cancer rehabilitation. And we know this because we go to the conferences and we see the people that come to the different lectures and the presenters. And we know that this is kind of a small world because we see that a lot of the same people over and over again. And, and so the education is really important, obviously for Kristin and I, we have it updated constantly by the presenters. Each one of them is responsible for their segment so that we know if legislation changes, if there's evidence that comes out, something happens where their presentation or their part of our education needs to be updated. Speaker 2 (28:42): That's going to happen in pretty, pretty much in real time. But how do we answer our students' questions later? How do we grow their interest or their confidence beyond just an online course and the way that Chris and I have been doing that, as you know, we've worked with clients and we've sort of built this community within our own clients, that they reach out to each other all the time and communicate in that way. They know they've got other people that are doing the same thing, implementing the same types of interventions or screenings or things like education. And so they can connect with each other. And that's great for those clients. But we've really recognized that there is there is a need for a community where people could really discuss their patients, discuss their experiences, discuss their education and grow from there. Speaker 2 (29:32): And so that's actually something that we're working on right now really hard. And we, we already, you know, it's rolled out for our clients right now. So it's just a matter of being able to make it more of a public forum where people can, they they've got this, they've had the education. So they kind of were speaking the same language, at least at a bare minimum. And then they can discuss and communicate. And what's nice about it is that we've got all of our partners who have created our course, like Nicole Stout and Mary Lou Valentino. And some of these others who are very reputable, well-known that created part of our course for us. And they're all in there like, heck yeah, we're going to be part of this conversation. We want to be part of this community. And so our vision of course, is that we can have discussion groups and different opportunities where people can get their questions answered about either about the education or applying that application, that education to real life scenarios. How can they get that feedback and that comradery that they're going to need to feel even more confident in this industry. That's why we have, that's why we have great relationships is that they all want to do this. They all know this community is important and it's not a big ask. It's not like, Hey, can you talk to a bunch of therapists that really think this is important? They're I mean, they're, they're all in it. They're all in. So Speaker 3 (30:51): Being an Island is, is kind of scary. And like you said, you take that education and then you go back into your clinic or your place. And for people that are working in rural communities, they may be the only person that is taking this education. And we're all really busy people in our work lives and our home lives. And I think one of the hardest things for me as a clinician and a business owner is what do I need to know right now? You know, there's so much research that comes out. And so that's how we also wanted to support with, with workshops. And you know, what is the need to know research that you need to know that's coming out today? You know, you can't afford to fly all over the country and go to all these conferences. Well, guess what, we've tidbit from all the conferences that now that's out there, that's pertinent to you so that you understand what's going on out there in the world without having to do that. Speaker 3 (31:43): And so it's you know, it has meant so much to Gillian and I to work with all of the partners that we have. All of the organizations that we work with are so passionate. We've met clinicians that are passionate. I've never met anyone that has not been exposed to cancer in some way, whether it's personally a friend, family, somebody, so everyone is connected by it. Nobody doesn't want to take care of somebody that's going through this. So it's really, how do we all kind of work together to support each other? That if you have questions kind of there in a non-threatening way. Certainly, you know, when Julia and I first met Nicole Stout, we were, you know, at, at, in section meeting and she was standing over there and, and, you know, Julie was like, I'm going to go over there and meet her. I'm like, no, no, it's Nicole Stone. You know? And I was so intimidated by her and because she was a big wig. Well, yeah, but when you meet her, you go, you meet her and you learn that she has the same passion and mission and commitment to people that you do. And, and she's so accepting and welcoming that, that really went away. And I felt like we had to really offer that to everybody else so that they could acknowledge that these people are, are very willing and receptive to helping. Speaker 1 (32:58): Yeah. Yeah. She's fabulous. Plus, I mean the shoe collection, I mean, I mean, can we just be envious of her shoe collection? And so, but yeah, she's, she's fabulous and what she does for the, for the physical therapy world oncology in particular. But I think the PT world as a whole is, is huge. As a student, she might, people might be intimidated by, by that. I mean, we were, but I think that that's what we're trying to do is as we're breaking down those, those barriers for our students, and we're saying, Hey, look, you know what your course is awesome as taught by an awesome person. And here's an awesome person that you can ask that question too. Yeah. Yeah. What a wonderful opportunity to give to your students to, to have to have those collaborations and those relationships, which in, in my, in my eyes, relationships are everything they're key. And, and that's the thing for me that keeps pushing this profession forward. As we wrap things up, I'm going to ask each of you. So what would be your big takeaway that you want the listeners to come away with from the talk today? Speaker 3 (34:09): I think one of the biggest things that I learned was actually back at CSM. And somebody said that as physical therapists, we are medical coordinators of care and is our ethical responsibility to really be able to take care of everybody that comes into our care. And he said, you know, what, if you're not competent to treat everybody get off the bus because you're bringing our profession down. You know, we have autonomy. Now we can have people coming into our clinics without physician referrals. So we have to know this many, many PTs can order x-rays and things like that. So my take home message is if you want to stay on the bus, get competent and elevate your skillset to everything, not just cancer rehabilitation, but add that as yet another skill in your pocket so that when that patient comes in, you can either treat them or you can triage them. A stroke patient comes into my clinic. I can evaluate them and educate them, but I might triage them somewhere else so that they get more targeted care. So that's, you know, I just want everybody to get on the bus. Yeah. Speaker 1 (35:20): Awesome. Jillian. Well I think my takeaway that I would provide it really depends on the audience on who is listening. So if you are a clinician or a therapist like Kristen, it really is Speaker 2 (35:38): Your ethical responsibility to take care of every therapy. Every patient that comes through the door, regardless of what their past medical history is you should be able to provide the highest level of care for that patient and as therapists. And we all know you have the heart of a therapist, you want to do the best for your patients. So if you are not confident and competent in taking care of oncology patients, my takeaway to you is get that way. There's a solution for you, educate yourself, feel comfortable, feel confident. You take care of your patients, where you said there's a solution for you. I'm an action girl, but my takeaway for administrators and for leadership teams of your organizations is you really want to know that your team can take care of this population. And when you do something, when you do something and you want to be sure that your team is competent, you put forth these standards and people have to meet these standards. Speaker 2 (36:31): And so my, my takeaway for then is that if you do not have something in place that is ensuring that your, your clinicians, that your rehabilitation teams are really competent in taking care of these patients you need to get that way and you need to get that way pretty quick because the regulations and the the requirements that are coming down from the very top levels nationally are requiring that you do that. So it's not just an ethical thing on the clinician side. It really, and, and also this is a new patient population or not, not a new patient population, but this is a patient population that is going to expand. We're going to see a lot more on ecology patients. And so that is an opportunity to reach out to sort of almost a new I don't want to call it a market cause I don't like to call people a market, but it is, it's a new, it's a new market for, for those administrators and most leaders. Speaker 2 (37:28): And then the takeaway, of course, if we have patients listening or, or relative caregivers coast survivors is what we call people that are in the lives of, of a person with a diagnosis of cancer. Ask for it. My takeaway is that this is part of your medical care. You should be, if you're not, if you're, if you're on ecologists, your provider is not talking to you about function and what's happening to you during your cancer journey and how that is going to be mitigated or how you're going to have a rehabilitation therapist of support as part of your team. If somebody has not said that to you yet ask for it because it needs to have this bottom up push as well. And it seems so logical when you talk about it. But again, you know, you gotta look, you gotta understand your audience and who are you talking to? What language are you speaking? Yeah. Speaker 1 (38:16): Excellent. All right. So before we get to where everyone can find you, I have last question, it's the question I ask everyone. And that is knowing where you are now in your life and in your career. What advice would you give to yourself as a new grad? Speaker 2 (38:33): I would tell my younger self or anybody that is kind of starting out in their career and they know they're doing what they love to think big, think big and be brave and just go, just go for it. Speaker 1 (38:48): Excellent. Kristen, Speaker 3 (38:50): I think that I would tell my younger self to just keep being a sponge, keep learning. Don't be afraid to try new things, you know, when you're starting to get burned out, try something else, which is what I did. I kind of kept jumping around and I found I was passionate about each of those things and just keep learning and keep growing. And eventually you're going to find something that really wows you and really makes you change not only your career, but your, you know, your personal growth as, as well. Speaker 1 (39:23): Excellent. Very good advice all around. So now where can people find you? Where can they find the course? What's the name of the course? Give me all the details. Speaker 2 (39:31): Great. but you can find us@survivorshipsolutions.com. That's our website and our courses on our homepage. So they can just click, click on the link, they'll see the education and they'll see some of the other, you know, consulting services and things like that that we also provide. But and certainly there's contact page. They can reach out to us. We're happy to, to have conversation with anybody. Speaker 1 (39:59): Perfect. And what about social media? Where can people find you follow you, et cetera? Speaker 3 (40:03): We are all over social media. We're on LinkedIn. We're on Twitter, on Instagram and I forgetting what's the other one, Facebook both personally and professionally where we're both on there. So maybe you can find us there. Speaker 1 (40:17): What are your handles? Speaker 3 (40:19): Our business handle is survivorship solutions for LinkedIn and for Twitter. It's survivorship Sol. Speaker 1 (40:26): Perfect. Excellent. And we will have the links to all of this at the show notes for this episode at podcast on healthy, wealthy, smart.com. So if you want to get more information on the course, follow them on social media become if you're a physical therapist out there listening, and you want to become competent and safe to treat patients, cancer patients, which we now know, we all will at some point then definitely check them out. So Kristin and Jillian, thank you so much for coming on. I appreciate your time. Speaker 2 (41:03): Thanks so much for having us. It's been our pleasure. Speaker 3 (41:06): Thanks, Cara. It's been fun. Thanks so much. Speaker 1 (41:08): And everyone, thanks so much for listening. Have a great couple of days and stay healthy, wealthy and smart.  

Welcome to episode 220 of the Sexology Podcast! Today I'm delighted to welcome Dr. Anne Katz to the podcast. In this episode Dr. Anne speaks with me about re-engaging with your sexuality after Cancer, how sexual health for cancer survivors can become a lost priority and learning to re-write your sexual script.    Dr. Anne Katz is the certified sexuality counsellor and Clinical Nurse Specialist at CancerCare Manitoba in Winnipeg, Canada. Dr. Katz is the immediate past editor of the Oncology Nursing Forum, the premier research journal of the Oncology Nursing Society. She was inducted into the American Academy of Nursing in 2014.      She is the author of 14books for health care providers and health care consumers on the topics of illness and sexuality as well as cancer survivorship. Her latest book, the second edition of Woman Cancer Sex, was published in late 2020 and she is completing her latest book about sexuality and illness.    In this episode, you will hear:     How Dr. Anne became involved in this line of work   Re-engaging with your sexuality after cancer  The first steps women can take on this journey  How sexual health for cancer survivors can become a lost priority   The way in which guilt can show up around sexuality and cancer  Analysing the sexual pain survivors experience   Learning to re-write your sexual script   Exploring non- penetrative sex   Looking at treatments and medications available   Re-connecting with your body for better sex   How people can benefit from sensate focus exercises     OMGyes   Thank you to our sponsor OMGyes! OMGyes.com is a website devoted to sexual pleasure for people with vulvas and their partners. OMGYES conducts and publishes the first-ever nationally representative large-scale studies about specific pleasure strategies, in partnership with Indiana University and Kinsey Institute researchers.     See for yourself and get a discount at – https://OMGyes.com/sexology      Clinicians, therapists and nurses get free personal access to OMGYES. Just email therapists@omgyes.com from your work email address with a link to your professional profile.    Likeakitten  We are so excited to celebrate women's history month! We’re teaming up with Likeakitten  to give away their signature box (worth $200).  To enter, follow us on Instagram, write a review in iTunes, screenshot it and send it via a DM. The winners will be announced on March 30th.    Check out the Signature Box for our giveaway here - https://likeakitten.com/product/the-signature-box/     Find Dr. Anne Katz Online  http://www.drannekatz.com     Find Dr. Moali online    http://www.sexologypodcast.com    Find me on social media  https://www.instagram.com/sexologypodcast  https://www.facebook.com/oasis2care      Sex Quiz for Women  https://oasis2care.com/sexquiz/     If you are interested in booking a video counselling session with Dr. Moali  https://oasis2care.com/contact-nazanin-moali-psychologist      Podcast Produced by Pete Bailey - http://petebailey.net/audio 

MiKaela Olsen DNP, APRN-CNS, AOCNS, FAAN discusses providing cancer care during a pandemic. Topics: *Protecting staff and patients from COVID-19 *Oncology Nursing Society guidelines for cancer care during COVID-19 *Innovative ways to deliver care *Algorithms to guide PPE use in oncology care *Treating the COVID-19+ cancer patient The post UPDATE 7/24/2020 – COVID-19: Keeping Up With A Moving Target appeared first on DKBmed Radio.

In the latest ASCO in Action Podcast, ASCO CEO Dr. Clifford A. Hudis provides an update on a new initiative, the ASCO Survey on COVID-19 in Oncology Registry (ASCO Registry), which aims to help the cancer community learn more about the pattern of symptoms and severity of COVID-19 among patients with cancer, as well as how the virus is impacting the delivery of cancer care and patient outcomes. “We have an urgent need to learn more about how COVID-19 is directly and indirectly affecting the people with cancer who we serve. In times of crisis, it’s especially important that we learn from every patient so that we can refine our approaches and continue to provide the highest quality care,” said Dr. Hudis. Subscribe to the ASCO in Action podcast through iTunes or Google Play.   The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care, and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy, should not be construed as an ASCO endorsement.   Welcome to this ASCO in Action podcast, brought to you by the ASCO Podcast Network, a collection of nine programs covering a range of educational and scientific content, and offering enriching insights into the world of cancer care. You can find all of the shows, including this one, at podcast.asco.org. The ASCO in Action Podcast is ASCO's Podcast Series, where we explore policy and practice issues that impact oncologists, the entire cancer care delivery team, and the individuals we care for, people with cancer.   My name is Dr. Clifford Hudis, and I'm the CEO of ASCO, as well as the host of the ASCO in Action Podcast Series. For today's podcast, I want to provide a quick update on one of ASCO's his newest initiatives, the ASCO Survey on COVID-19 and Oncology Registry, which we've launched in response to the COVID-19 pandemic.   Now, it is clear that the COVID-19 pandemic poses a unique threat to people all across the globe. Since the worldwide outbreak of the coronavirus, we've learned that some populations, including people with cancer, are even more likely to have worse outcomes and be especially vulnerable to COVID-19. However, there is still a lot that we do not understand, and we have an urgent need to learn more about how COVID-19 is directly and indirectly affecting people with cancer who are the people we serve.   In response, ASCO recently announced the new ASCO survey on COVID-19 and Oncology Registry, or ASCO Registry, for short. This new initiative was developed under the leadership and vision of ASCO's chief medical officer, Dr. Richard Schilsky, with support from a dedicated team of professional staff who work with him in our Center for Research Analytics, also known as CENTRA. The ASCO Registry was established so that we can learn more about the pattern of symptoms and the severity of COVID-19 among patients with cancer.   We also want to learn how the is impacting the delivery of cancer care, and what it is doing to patient outcomes. We're not just looking at a point in time for these patients either. The ASCO Registry instead will capture longitudinal data on how the virus impacts patient care and outcomes throughout the COVID-19 pandemic and into 2021. We hope that this longer term look will tell us if the virus resulted in specific complications for patients, if it delayed patient's ability to get specific types of care or treatment, and if specific certain approaches resulted in better outcomes for patients.   Once we have sufficient data in the registry, we plan to release periodic reports to the cancer community, as well as to the broader public summarizing our key learnings. These reports might include details, like the characteristics of patients with cancer most impacted by COVID-19, estimates of the severity of the disease among patients with cancer, changes or delays in their treatment, and the implementation of telehealth in the cancer care setting. We also hope to be able to report on the clinical outcomes seen among patients with cancer throughout the pandemic, and we might even learn that certain unconventional approaches could allow us to deliver care more efficiently or safely in the future without jeopardizing patient outcomes.   The ASCO Registry is now open to all US oncology practices. This includes physician owned, academic, hospital, or health system own practices, as well as hospitals themselves. Participating practices will be asked to complete a baseline data capture form on each patient with cancer who also has a confirmed case of COVID-19.   Later, these practices will then be asked to provide follow-up information on each patient's status, treatment, and outcomes. The data will be collected on practice level changes, such as new screening procedures, implementation of telehealth in the practice, and changes to the clinical trial enrollment procedures. The ASCO Registry will securely collect limited patient identifying data. This might include zip code, date of birth, gender, race, ethnicity, type of cancer, and comorbidities. But by collecting this type of data, it will then be possible for us to conduct longitudinal analysis.   Data from practices that participate in the registry will be collected and securely stored in the CancerLinQ platform. We're not alone in our work to better understand the impact of COVID-19 on cancer care and on the patients who we serve. There are other registries including, the COVID-19 and Cancer Consortium or CCC19 and the American Society of Hematology Research Collaborative COVID-19 REGISTRY for Hematologic Malignancy.   The ASH Registry, as well as CCC19 Registry have already been launched, and there are other multi-site registries in development. We're encouraging all oncology practices to participate in one or more of these registries based on their specific needs and based on the patients they serve. Each of these registries has a different focus and a different timeline, so participating in multiple registries will not compromise our efforts, nor will it prevent the organizations involved from working together. We're actively looking for opportunities to collaborate with our colleagues on these initiatives.   The ASCO Registry is part of our ongoing efforts to provide the most current information and resources on the virus to our members and to the larger oncology community. We've developed a wide variety of COVID-19 resources to support clinicians, the cancer care delivery team, and patients with cancer. Some of these resources include, patient care guidance for oncologists who are treating patients with cancer during the COVID-19 pandemic, they also include guidance for practices on how our adjust policies and procedures in response to the virus, and finally, they include updates on federal activities that are responsive to the crisis.   At the same time, we are co-hosting a weekly webinar series with the Oncology Nursing Society, or ONS, on COVID-19. Each of these webinars examines a range of issues and are designed to help clinicians care for people with cancer during the pandemic. You can find all of these resources and more at asco.org. In addition, there are patient focused resources available at cancer.net.   So as we conclude, I want to again invite all of our listeners to learn more about the ASCO Registry by going to asco.org on the web. In times of crisis, it is especially important that we learn from every patient so that we can refine our approaches and continue to deliver the highest quality of care come what may. So until next time, I want to thank you for listening to this ASCO in Action Podcast.   And if you enjoyed what you heard today, don't forget to give us a rating or a review on Apple Podcasts, or wherever you listen. And while you're there, be sure to subscribe so you never miss an episode. The ASCO in Action Podcast is just one of ASCO's many podcasts. You can find all of the shows at podcast.asco.org.

In this podcast with AJN editor-in-chief Shawn Kennedy, Lisa Kennedy Sheldon discusses special COVID-19–related concerns for patients undergoing chemotherapy and for nurses who now may not have protective equipment necessary for handling toxic medications.

In this podcast with AJN editor-in-chief Shawn Kennedy, Lisa Kennedy Sheldon discusses special COVID-19–related concerns for patients undergoing chemotherapy and for nurses who now may not have protective equipment necessary for handling toxic medications.

Oncology nurses are at the forefront of care for patients with pancreatic cancer, a much-feared disease whose management was for years characterized by modestly effective treatment options. The recent emergence of new cytotoxic platforms combined with rapid research on potent targeted therapies has made the role of the nurse as a caregiver and educator more important than ever, particularly because these new options differ greatly from conventional chemotherapy strategies. In this activity based on a recent live symposium held in Anaheim during the Oncology Nursing Society's (ONS) 44th Annual Congress, expert nurse faculty use a patient-voice inclusive MasterClass designed to provide real-world guidance for effective translation of the latest evidence into clinical practice. In addition, the experts offer their perspectives on the unique needs and concerns of patients, and how engagement strategies can shape individualized, patient-centric management plans throughout the continuum of pancreatic cancer care. This activity also features perspectives from pancreatic cancer patients developed in collaboration with Let's Win, an affiliate of the Lustgarten Foundation. Upon completion of this activity, participants will be able to: Summarize updated efficacy and safety evidence on therapeutic strategies in pancreatic cancer, including cytotoxic platforms and chemotherapy sequencing approaches, targeted agents directed against molecular features/mutations, or tumor treating field therapy, among others, Educate patients on the clinical uses and potential of clinical trials investigating novel therapeutics alone and in combination with cytotoxic regimens in the pancreatic cancer setting, Provide guidance to patients on therapeutic sequencing with cytotoxic platforms in advanced pancreatic cancer based upon available evidence, guideline recommendations, and disease- and patient-specific characteristics, Manage adverse events associated with established and emerging therapies for pancreatic cancer.

Oncology nurses are at the forefront of care for patients with pancreatic cancer, a much-feared disease whose management was for years characterized by modestly effective treatment options. The recent emergence of new cytotoxic platforms combined with rapid research on potent targeted therapies has made the role of the nurse as a caregiver and educator more important than ever, particularly because these new options differ greatly from conventional chemotherapy strategies. In this activity based on a recent live symposium held in Anaheim during the Oncology Nursing Society's (ONS) 44th Annual Congress, expert nurse faculty use a patient-voice inclusive MasterClass designed to provide real-world guidance for effective translation of the latest evidence into clinical practice. In addition, the experts offer their perspectives on the unique needs and concerns of patients, and how engagement strategies can shape individualized, patient-centric management plans throughout the continuum of pancreatic cancer care. This activity also features perspectives from pancreatic cancer patients developed in collaboration with Let's Win, an affiliate of the Lustgarten Foundation. Upon completion of this activity, participants will be able to: Summarize updated efficacy and safety evidence on therapeutic strategies in pancreatic cancer, including cytotoxic platforms and chemotherapy sequencing approaches, targeted agents directed against molecular features/mutations, or tumor treating field therapy, among others, Educate patients on the clinical uses and potential of clinical trials investigating novel therapeutics alone and in combination with cytotoxic regimens in the pancreatic cancer setting, Provide guidance to patients on therapeutic sequencing with cytotoxic platforms in advanced pancreatic cancer based upon available evidence, guideline recommendations, and disease- and patient-specific characteristics, Manage adverse events associated with established and emerging therapies for pancreatic cancer.

Oncology nurses are at the forefront of care for patients with pancreatic cancer, a much-feared disease whose management was for years characterized by modestly effective treatment options. The recent emergence of new cytotoxic platforms combined with rapid research on potent targeted therapies has made the role of the nurse as a caregiver and educator more important than ever, particularly because these new options differ greatly from conventional chemotherapy strategies. In this activity based on a recent live symposium held in Anaheim during the Oncology Nursing Society's (ONS) 44th Annual Congress, expert nurse faculty use a patient-voice inclusive MasterClass designed to provide real-world guidance for effective translation of the latest evidence into clinical practice. In addition, the experts offer their perspectives on the unique needs and concerns of patients, and how engagement strategies can shape individualized, patient-centric management plans throughout the continuum of pancreatic cancer care. This activity also features perspectives from pancreatic cancer patients developed in collaboration with Let's Win, an affiliate of the Lustgarten Foundation. Upon completion of this activity, participants will be able to: Summarize updated efficacy and safety evidence on therapeutic strategies in pancreatic cancer, including cytotoxic platforms and chemotherapy sequencing approaches, targeted agents directed against molecular features/mutations, or tumor treating field therapy, among others, Educate patients on the clinical uses and potential of clinical trials investigating novel therapeutics alone and in combination with cytotoxic regimens in the pancreatic cancer setting, Provide guidance to patients on therapeutic sequencing with cytotoxic platforms in advanced pancreatic cancer based upon available evidence, guideline recommendations, and disease- and patient-specific characteristics, Manage adverse events associated with established and emerging therapies for pancreatic cancer.

Oncology nurses are at the forefront of care for patients with pancreatic cancer, a much-feared disease whose management was for years characterized by modestly effective treatment options. The recent emergence of new cytotoxic platforms combined with rapid research on potent targeted therapies has made the role of the nurse as a caregiver and educator more important than ever, particularly because these new options differ greatly from conventional chemotherapy strategies. In this activity based on a recent live symposium held in Anaheim during the Oncology Nursing Society's (ONS) 44th Annual Congress, expert nurse faculty use a patient-voice inclusive MasterClass designed to provide real-world guidance for effective translation of the latest evidence into clinical practice. In addition, the experts offer their perspectives on the unique needs and concerns of patients, and how engagement strategies can shape individualized, patient-centric management plans throughout the continuum of pancreatic cancer care. This activity also features perspectives from pancreatic cancer patients developed in collaboration with Let's Win, an affiliate of the Lustgarten Foundation. Upon completion of this activity, participants will be able to: Summarize updated efficacy and safety evidence on therapeutic strategies in pancreatic cancer, including cytotoxic platforms and chemotherapy sequencing approaches, targeted agents directed against molecular features/mutations, or tumor treating field therapy, among others, Educate patients on the clinical uses and potential of clinical trials investigating novel therapeutics alone and in combination with cytotoxic regimens in the pancreatic cancer setting, Provide guidance to patients on therapeutic sequencing with cytotoxic platforms in advanced pancreatic cancer based upon available evidence, guideline recommendations, and disease- and patient-specific characteristics, Manage adverse events associated with established and emerging therapies for pancreatic cancer.

Oncology nurses are at the forefront of care for patients with pancreatic cancer, a much-feared disease whose management was for years characterized by modestly effective treatment options. The recent emergence of new cytotoxic platforms combined with rapid research on potent targeted therapies has made the role of the nurse as a caregiver and educator more important than ever, particularly because these new options differ greatly from conventional chemotherapy strategies. In this activity based on a recent live symposium held in Anaheim during the Oncology Nursing Society's (ONS) 44th Annual Congress, expert nurse faculty use a patient-voice inclusive MasterClass designed to provide real-world guidance for effective translation of the latest evidence into clinical practice. In addition, the experts offer their perspectives on the unique needs and concerns of patients, and how engagement strategies can shape individualized, patient-centric management plans throughout the continuum of pancreatic cancer care. This activity also features perspectives from pancreatic cancer patients developed in collaboration with Let's Win, an affiliate of the Lustgarten Foundation. Upon completion of this activity, participants will be able to: Summarize updated efficacy and safety evidence on therapeutic strategies in pancreatic cancer, including cytotoxic platforms and chemotherapy sequencing approaches, targeted agents directed against molecular features/mutations, or tumor treating field therapy, among others, Educate patients on the clinical uses and potential of clinical trials investigating novel therapeutics alone and in combination with cytotoxic regimens in the pancreatic cancer setting, Provide guidance to patients on therapeutic sequencing with cytotoxic platforms in advanced pancreatic cancer based upon available evidence, guideline recommendations, and disease- and patient-specific characteristics, Manage adverse events associated with established and emerging therapies for pancreatic cancer.

Oncology nurses are at the forefront of care for patients with pancreatic cancer, a much-feared disease whose management was for years characterized by modestly effective treatment options. The recent emergence of new cytotoxic platforms combined with rapid research on potent targeted therapies has made the role of the nurse as a caregiver and educator more important than ever, particularly because these new options differ greatly from conventional chemotherapy strategies. In this activity based on a recent live symposium held in Anaheim during the Oncology Nursing Society's (ONS) 44th Annual Congress, expert nurse faculty use a patient-voice inclusive MasterClass designed to provide real-world guidance for effective translation of the latest evidence into clinical practice. In addition, the experts offer their perspectives on the unique needs and concerns of patients, and how engagement strategies can shape individualized, patient-centric management plans throughout the continuum of pancreatic cancer care. This activity also features perspectives from pancreatic cancer patients developed in collaboration with Let's Win, an affiliate of the Lustgarten Foundation. Upon completion of this activity, participants will be able to: Summarize updated efficacy and safety evidence on therapeutic strategies in pancreatic cancer, including cytotoxic platforms and chemotherapy sequencing approaches, targeted agents directed against molecular features/mutations, or tumor treating field therapy, among others, Educate patients on the clinical uses and potential of clinical trials investigating novel therapeutics alone and in combination with cytotoxic regimens in the pancreatic cancer setting, Provide guidance to patients on therapeutic sequencing with cytotoxic platforms in advanced pancreatic cancer based upon available evidence, guideline recommendations, and disease- and patient-specific characteristics, Manage adverse events associated with established and emerging therapies for pancreatic cancer.

Oncology nurses are at the forefront of care for patients with pancreatic cancer, a much-feared disease whose management was for years characterized by modestly effective treatment options. The recent emergence of new cytotoxic platforms combined with rapid research on potent targeted therapies has made the role of the nurse as a caregiver and educator more important than ever, particularly because these new options differ greatly from conventional chemotherapy strategies. In this activity based on a recent live symposium held in Anaheim during the Oncology Nursing Society's (ONS) 44th Annual Congress, expert nurse faculty use a patient-voice inclusive MasterClass designed to provide real-world guidance for effective translation of the latest evidence into clinical practice. In addition, the experts offer their perspectives on the unique needs and concerns of patients, and how engagement strategies can shape individualized, patient-centric management plans throughout the continuum of pancreatic cancer care. This activity also features perspectives from pancreatic cancer patients developed in collaboration with Let's Win, an affiliate of the Lustgarten Foundation. Upon completion of this activity, participants will be able to: Summarize updated efficacy and safety evidence on therapeutic strategies in pancreatic cancer, including cytotoxic platforms and chemotherapy sequencing approaches, targeted agents directed against molecular features/mutations, or tumor treating field therapy, among others, Educate patients on the clinical uses and potential of clinical trials investigating novel therapeutics alone and in combination with cytotoxic regimens in the pancreatic cancer setting, Provide guidance to patients on therapeutic sequencing with cytotoxic platforms in advanced pancreatic cancer based upon available evidence, guideline recommendations, and disease- and patient-specific characteristics, Manage adverse events associated with established and emerging therapies for pancreatic cancer.

Oncology nurses are at the forefront of care for patients with pancreatic cancer, a much-feared disease whose management was for years characterized by modestly effective treatment options. The recent emergence of new cytotoxic platforms combined with rapid research on potent targeted therapies has made the role of the nurse as a caregiver and educator more important than ever, particularly because these new options differ greatly from conventional chemotherapy strategies. In this activity based on a recent live symposium held in Anaheim during the Oncology Nursing Society's (ONS) 44th Annual Congress, expert nurse faculty use a patient-voice inclusive MasterClass designed to provide real-world guidance for effective translation of the latest evidence into clinical practice. In addition, the experts offer their perspectives on the unique needs and concerns of patients, and how engagement strategies can shape individualized, patient-centric management plans throughout the continuum of pancreatic cancer care. This activity also features perspectives from pancreatic cancer patients developed in collaboration with Let's Win, an affiliate of the Lustgarten Foundation. Upon completion of this activity, participants will be able to: Summarize updated efficacy and safety evidence on therapeutic strategies in pancreatic cancer, including cytotoxic platforms and chemotherapy sequencing approaches, targeted agents directed against molecular features/mutations, or tumor treating field therapy, among others, Educate patients on the clinical uses and potential of clinical trials investigating novel therapeutics alone and in combination with cytotoxic regimens in the pancreatic cancer setting, Provide guidance to patients on therapeutic sequencing with cytotoxic platforms in advanced pancreatic cancer based upon available evidence, guideline recommendations, and disease- and patient-specific characteristics, Manage adverse events associated with established and emerging therapies for pancreatic cancer.

Go online to PeerView.com/XAC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live symposium held during the Oncology Nursing Society's (ONS) 44th Annual Congress, a panel of expert nurse faculty use a MasterClass/case-forum design to offer an in-depth review of BTK inhibitors, their therapeutic applications in B-cell malignancies, and the core nurse-focused practice issues that are central to the further integration of BTK inhibitors into treatment plans for patients with cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), among other B-cell disorders. Upon completion of this activity, participants will be able to: Summarize updated safety and efficacy evidence about first- and second-generation BTK inhibitors in the management of B-cell cancer, Cite dosing considerations, administration strategies, and treatment schedules of BTK inhibitors for the management of newly diagnosed or refractory/relapsed B-cell cancer, Educate patients about the varying side effect profiles, efficacy outcomes, and potential for treatment resistance associated with the use of BTK inhibitors for B-cell cancer, Manage side effect and adherence considerations in patients with B-cell cancer treated with BTK inhibitors.

Go online to PeerView.com/XAC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live symposium held during the Oncology Nursing Society's (ONS) 44th Annual Congress, a panel of expert nurse faculty use a MasterClass/case-forum design to offer an in-depth review of BTK inhibitors, their therapeutic applications in B-cell malignancies, and the core nurse-focused practice issues that are central to the further integration of BTK inhibitors into treatment plans for patients with cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), among other B-cell disorders. Upon completion of this activity, participants will be able to: Summarize updated safety and efficacy evidence about first- and second-generation BTK inhibitors in the management of B-cell cancer, Cite dosing considerations, administration strategies, and treatment schedules of BTK inhibitors for the management of newly diagnosed or refractory/relapsed B-cell cancer, Educate patients about the varying side effect profiles, efficacy outcomes, and potential for treatment resistance associated with the use of BTK inhibitors for B-cell cancer, Manage side effect and adherence considerations in patients with B-cell cancer treated with BTK inhibitors.

Go online to PeerView.com/XAC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live symposium held during the Oncology Nursing Society's (ONS) 44th Annual Congress, a panel of expert nurse faculty use a MasterClass/case-forum design to offer an in-depth review of BTK inhibitors, their therapeutic applications in B-cell malignancies, and the core nurse-focused practice issues that are central to the further integration of BTK inhibitors into treatment plans for patients with cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), among other B-cell disorders. Upon completion of this activity, participants will be able to: Summarize updated safety and efficacy evidence about first- and second-generation BTK inhibitors in the management of B-cell cancer, Cite dosing considerations, administration strategies, and treatment schedules of BTK inhibitors for the management of newly diagnosed or refractory/relapsed B-cell cancer, Educate patients about the varying side effect profiles, efficacy outcomes, and potential for treatment resistance associated with the use of BTK inhibitors for B-cell cancer, Manage side effect and adherence considerations in patients with B-cell cancer treated with BTK inhibitors.

Go online to PeerView.com/XAC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live symposium held during the Oncology Nursing Society's (ONS) 44th Annual Congress, a panel of expert nurse faculty use a MasterClass/case-forum design to offer an in-depth review of BTK inhibitors, their therapeutic applications in B-cell malignancies, and the core nurse-focused practice issues that are central to the further integration of BTK inhibitors into treatment plans for patients with cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), among other B-cell disorders. Upon completion of this activity, participants will be able to: Summarize updated safety and efficacy evidence about first- and second-generation BTK inhibitors in the management of B-cell cancer, Cite dosing considerations, administration strategies, and treatment schedules of BTK inhibitors for the management of newly diagnosed or refractory/relapsed B-cell cancer, Educate patients about the varying side effect profiles, efficacy outcomes, and potential for treatment resistance associated with the use of BTK inhibitors for B-cell cancer, Manage side effect and adherence considerations in patients with B-cell cancer treated with BTK inhibitors.

Go online to PeerView.com/XAC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live symposium held during the Oncology Nursing Society's (ONS) 44th Annual Congress, a panel of expert nurse faculty use a MasterClass/case-forum design to offer an in-depth review of BTK inhibitors, their therapeutic applications in B-cell malignancies, and the core nurse-focused practice issues that are central to the further integration of BTK inhibitors into treatment plans for patients with cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), among other B-cell disorders. Upon completion of this activity, participants will be able to: Summarize updated safety and efficacy evidence about first- and second-generation BTK inhibitors in the management of B-cell cancer, Cite dosing considerations, administration strategies, and treatment schedules of BTK inhibitors for the management of newly diagnosed or refractory/relapsed B-cell cancer, Educate patients about the varying side effect profiles, efficacy outcomes, and potential for treatment resistance associated with the use of BTK inhibitors for B-cell cancer, Manage side effect and adherence considerations in patients with B-cell cancer treated with BTK inhibitors.

Go online to PeerView.com/XAC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live symposium held during the Oncology Nursing Society's (ONS) 44th Annual Congress, a panel of expert nurse faculty use a MasterClass/case-forum design to offer an in-depth review of BTK inhibitors, their therapeutic applications in B-cell malignancies, and the core nurse-focused practice issues that are central to the further integration of BTK inhibitors into treatment plans for patients with cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), among other B-cell disorders. Upon completion of this activity, participants will be able to: Summarize updated safety and efficacy evidence about first- and second-generation BTK inhibitors in the management of B-cell cancer, Cite dosing considerations, administration strategies, and treatment schedules of BTK inhibitors for the management of newly diagnosed or refractory/relapsed B-cell cancer, Educate patients about the varying side effect profiles, efficacy outcomes, and potential for treatment resistance associated with the use of BTK inhibitors for B-cell cancer, Manage side effect and adherence considerations in patients with B-cell cancer treated with BTK inhibitors.

Go online to PeerView.com/XAC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live symposium held during the Oncology Nursing Society's (ONS) 44th Annual Congress, a panel of expert nurse faculty use a MasterClass/case-forum design to offer an in-depth review of BTK inhibitors, their therapeutic applications in B-cell malignancies, and the core nurse-focused practice issues that are central to the further integration of BTK inhibitors into treatment plans for patients with cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), among other B-cell disorders. Upon completion of this activity, participants will be able to: Summarize updated safety and efficacy evidence about first- and second-generation BTK inhibitors in the management of B-cell cancer, Cite dosing considerations, administration strategies, and treatment schedules of BTK inhibitors for the management of newly diagnosed or refractory/relapsed B-cell cancer, Educate patients about the varying side effect profiles, efficacy outcomes, and potential for treatment resistance associated with the use of BTK inhibitors for B-cell cancer, Manage side effect and adherence considerations in patients with B-cell cancer treated with BTK inhibitors.

Go online to PeerView.com/XAC860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, based on a recent live symposium held during the Oncology Nursing Society's (ONS) 44th Annual Congress, a panel of expert nurse faculty use a MasterClass/case-forum design to offer an in-depth review of BTK inhibitors, their therapeutic applications in B-cell malignancies, and the core nurse-focused practice issues that are central to the further integration of BTK inhibitors into treatment plans for patients with cancers such as chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL), among other B-cell disorders. Upon completion of this activity, participants will be able to: Summarize updated safety and efficacy evidence about first- and second-generation BTK inhibitors in the management of B-cell cancer, Cite dosing considerations, administration strategies, and treatment schedules of BTK inhibitors for the management of newly diagnosed or refractory/relapsed B-cell cancer, Educate patients about the varying side effect profiles, efficacy outcomes, and potential for treatment resistance associated with the use of BTK inhibitors for B-cell cancer, Manage side effect and adherence considerations in patients with B-cell cancer treated with BTK inhibitors.

An interview with Dr. Paul Celano from the greater Baltimore Medical Center, lead author on "Safe Handling of Hazardous Drugs: ASCO Standards." TRANSCRIPT The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Hello and welcome to the ASCO Guidelines podcast series. My name is Shannon McKernin. And today I'm interviewing Dr. Paul Celano from the greater Baltimore Medical Center, lead author on "Safe Handling of Hazardous Drugs: ASCO Standards." Thank you for being here today, Dr. Celano. Thank you for having me. I'm certainly glad to talk about these standards. They're very important to our employees and our patients. So first I want to make the distinction that this publication is not a guideline like we usually cover on this podcast. So can you tell us what standards are and how they differ from guidelines? Well, guidelines really are intended to guide practitioners around recommended care options. They give obviously a lot of latitude to clinical judgment and circumstances. Standards, on the other hand, are really meant primarily for the organization of care and are intended to have a higher level of obligation to help drive either practice or policy or even legislative efforts. So that's really the distinction. And what are the standard statements that are made by ASCO in this publication? The publication really is about safe handling of hazardous drugs. This all came about is because recently there have been a number of national guidelines or standards that have been offered by other organizations, but not specifically oncology or certainly ASCO or the ASCO organization. We felt a need to address the standards that have been put out on the basis of the evidence, so that best practices can be offered. Initially, we did collaborate with other societies, such as the Oncology Nursing Society and the Hematology Oncology Pharmacy Association. That was really the impetus behind making sure that we are, in a sense, congruent with standards that are already being published and discussed, but also to also place in our interpretation of these standards so that they're based on the best evidence that's available. And what qualifying statements are there to note about these standards? Well, I think the best way to look at these standards is there has been recently published or offered what's been called the UST 800 standards, which really incorporate other previous standards by the Pharmacy Association as well as OSHA, the Occupational Safety and Health Association, as well as NIOSH, the American Society of Hospital Pharmacists, Oncology Nursing, etc. So there's a lot of standards that have been offered. And in fact, the ASCO review of this really in a sense agrees with many of the standards that have already been published and offered-- types of exposures, the responsibilities of personnel handling the drugs, the personal protective equipment, how we communicate the hazardous drugs, the training of compounding personnel, how the drugs are dispensed and even transported. So there's lots of things that we really do agree with. I think it's also important to understand that the objectives of this is really to protect personnel and the environment to make sure the standards apply to all personnel who compound hazardous drugs and preparations, all places where hazardous drugs are prepared and stored, transported and administered. So that's really a key part of this. These are a comprehensive program really to prevent worker environmental exposure and to provide the most practical safety environment for all involved. So finally, why are these standards so important? And how will they affect practice? Well, they effect practice in many ways. I mean, the key thing is making sure that our employees, meaning the nurses, pharmacy, the technicians, really everyone involved that they're not unduly exposed to these hazardous drugs. And so that's really the key thing that we're all trying to achieve by this. Now, what really makes the sort of ASCO standards somewhat different or the things that we came into a contention with has to do with the differences that ASCO has come up with in contrast to some of the other standards. And these have to do with really four main areas within these standards. They have to do with medical surveillance, external ventilation, closed system transfer devices, and also proper assignment of our personnel while they may have either trying to conceive or pregnant or nursing. So those areas that in our review, the ASCO review, have come under some question. As an example, medical surveillance, there in some of the standards offered-- not ASCO's-- that there's a number of medical surveillance procedures that have been elucidated, that really we find, number one, have really not any proven value for our employees and generate a lot of confusion in terms of how this process is supposed to be done. Obviously, if one of our employees has some undue exposure, such as a spill of chemotherapy or even just have flat out a concern, then obviously those things will be clearly investigated. But to have general medical surveillance of all employees, really we did not feel was of great value. But also further, we really feel that this is an area where more research needs to be done to better elucidate really what should this process look like and what value are we providing to our employees. Another aspect of this is the use of what are called closed system transfer devices. Currently, there are a number of these devices available that there is interestingly no standard way that these devices have been evaluated. And so it's hard to recommend one device over another, because there is no standards for which they're really being compared. And there certainly have been no studies looking at really any form of health outcome that really help us to direct this to how best to use these devices. And so really, a lot of these objections are more around let's do things in an evidence-based way so we can better know how to best direct our practices. Another area of concern in terms of ASCO standards have been the implementation of external ventilation in either containment secondary engineering controls or other situations. And the challenges is that HEPA filters are probably appropriate for collecting solid or aerosolized particles, but don't capture vaporized drugs. But there's little data available on the ability of hazardous drugs to vaporize within the workplace environment and what those hazards really are. And so again, it's is a call for more research to have an optimal environment for preparing these drugs and without having to place undue burdens in terms of external ventilation. Another area is options for alternative duties for workers who are actively trying to conceive or are pregnant or breastfeeding. And these we recognize can be special burdens to small practices looking to implement alternative duty programs. There is a lot of controversy regarding the potential level of risk that really these workers really have. And basically our stance has been that we should have a policy that identifies alternative work options for workers who are trying to conceive, are pregnant or are breastfeeding, and that this information needs to be conveyed to these employees at the time of their hire so they understand what their risks are and what their options are within the workplace. Again, trying to make sure everyone is well informed and aware of what the work environment they're in and as their life circumstances change what they can do to change with this. I think the key is that we all feel that this is an area that we should have continued research on. And our standard, certainly ASCO's standards will continue to evolve as more and more research and evidence becomes available. Thank you so much for taking the time to explain these standards to us today, Dr. Celano. You're welcome. And thank you to all of our listeners for tuning into the ASCO Guidelines podcast series. If you've enjoyed what you've heard today, please rate and review the podcast and refer the show to a colleague

The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement. Hello and welcome to the ASCO Guidelines podcast series. My name is Shannon McKernin. And today I'm interviewing Dr. Paul Celano from the greater Baltimore Medical Center, lead author on "Safe Handling of Hazardous Drugs: ASCO Standards." Thank you for being here today, Dr. Celano. Thank you for having me. I'm certainly glad to talk about these standards. They're very important to our employees and our patients. So first I want to make the distinction that this publication is not a guideline like we usually cover on this podcast. So can you tell us what standards are and how they differ from guidelines? Well, guidelines really are intended to guide practitioners around recommended care options. They give obviously a lot of latitude to clinical judgment and circumstances. Standards, on the other hand, are really meant primarily for the organization of care and are intended to have a higher level of obligation to help drive either practice or policy or even legislative efforts. So that's really the distinction. And what are the standard statements that are made by ASCO in this publication? The publication really is about safe handling of hazardous drugs. This all came about is because recently there have been a number of national guidelines or standards that have been offered by other organizations, but not specifically oncology or certainly ASCO or the ASCO organization. We felt a need to address the standards that have been put out on the basis of the evidence, so that best practices can be offered. Initially, we did collaborate with other societies, such as the Oncology Nursing Society and the Hematology Oncology Pharmacy Association. That was really the impetus behind making sure that we are, in a sense, congruent with standards that are already being published and discussed, but also to also place in our interpretation of these standards so that they're based on the best evidence that's available. And what qualifying statements are there to note about these standards? Well, I think the best way to look at these standards is there has been recently published or offered what's been called the UST 800 standards, which really incorporate other previous standards by the Pharmacy Association as well as OSHA, the Occupational Safety and Health Association, as well as NIOSH, the American Society of Hospital Pharmacists, Oncology Nursing, etc. So there's a lot of standards that have been offered. And in fact, the ASCO review of this really in a sense agrees with many of the standards that have already been published and offered-- types of exposures, the responsibilities of personnel handling the drugs, the personal protective equipment, how we communicate the hazardous drugs, the training of compounding personnel, how the drugs are dispensed and even transported. So there's lots of things that we really do agree with. I think it's also important to understand that the objectives of this is really to protect personnel and the environment to make sure the standards apply to all personnel who compound hazardous drugs and preparations, all places where hazardous drugs are prepared and stored, transported and administered. So that's really a key part of this. These are a comprehensive program really to prevent worker environmental exposure and to provide the most practical safety environment for all involved. So finally, why are these standards so important? And how will they affect practice? Well, they effect practice in many ways. I mean, the key thing is making sure that our employees, meaning the nurses, pharmacy, the technicians, really everyone involved that they're not unduly exposed to these hazardous drugs. And so that's really the key thing that we're all trying to achieve by this. Now, what really makes the sort of ASCO standards somewhat different or the things that we came into a contention with has to do with the differences that ASCO has come up with in contrast to some of the other standards. And these have to do with really four main areas within these standards. They have to do with medical surveillance, external ventilation, closed system transfer devices, and also proper assignment of our personnel while they may have either trying to conceive or pregnant or nursing. So those areas that in our review, the ASCO review, have come under some question. As an example, medical surveillance, there in some of the standards offered-- not ASCO's-- that there's a number of medical surveillance procedures that have been elucidated, that really we find, number one, have really not any proven value for our employees and generate a lot of confusion in terms of how this process is supposed to be done. Obviously, if one of our employees has some undue exposure, such as a spill of chemotherapy or even just have flat out a concern, then obviously those things will be clearly investigated. But to have general medical surveillance of all employees, really we did not feel was of great value. But also further, we really feel that this is an area where more research needs to be done to better elucidate really what should this process look like and what value are we providing to our employees. Another aspect of this is the use of what are called closed system transfer devices. Currently, there are a number of these devices available that there is interestingly no standard way that these devices have been evaluated. And so it's hard to recommend one device over another, because there is no standards for which they're really being compared. And there certainly have been no studies looking at really any form of health outcome that really help us to direct this to how best to use these devices. And so really, a lot of these objections are more around let's do things in an evidence-based way so we can better know how to best direct our practices. Another area of concern in terms of ASCO standards have been the implementation of external ventilation in either containment secondary engineering controls or other situations. And the challenges is that HEPA filters are probably appropriate for collecting solid or aerosolized particles, but don't capture vaporized drugs. But there's little data available on the ability of hazardous drugs to vaporize within the workplace environment and what those hazards really are. And so again, it's is a call for more research to have an optimal environment for preparing these drugs and without having to place undue burdens in terms of external ventilation. Another area is options for alternative duties for workers who are actively trying to conceive or are pregnant or breastfeeding. And these we recognize can be special burdens to small practices looking to implement alternative duty programs. There is a lot of controversy regarding the potential level of risk that really these workers really have. And basically our stance has been that we should have a policy that identifies alternative work options for workers who are trying to conceive, are pregnant or are breastfeeding, and that this information needs to be conveyed to these employees at the time of their hire so they understand what their risks are and what their options are within the workplace. Again, trying to make sure everyone is well informed and aware of what the work environment they're in and as their life circumstances change what they can do to change with this. I think the key is that we all feel that this is an area that we should have continued research on. And our standard, certainly ASCO's standards will continue to evolve as more and more research and evidence becomes available. Thank you so much for taking the time to explain these standards to us today, Dr. Celano. You're welcome. And thank you to all of our listeners for tuning into the ASCO Guidelines podcast series. If you've enjoyed what you've heard today, please rate and review the podcast and refer the show to a colleague

Dr Schneider talks to ecancertv at EONS 10 about the work and aims of the Oncology Nursing Society. Their work is extensive and includes capacity building, advocacy, and networking events, she says. They have also been involved in President Obama's 'Moonshot Initiative' to significantly improve cancer care and treatments in five years instead of ten.

Kris LeFebvre talks to ecancer at ICCN 17, in Prague, about the creation, implementation and review of the Chemotherapy Safety Standards. Started in 2008 with the aim to create standard guidelines for patients receiving chemotherapy as safely as possible, it began by putting together planning teams, literature reviews and mapping out the process of administering chemotherapy. By 2011, oral chemotherapy was being administered more frequently and monitoring this type of treatment was difficult for health care providers, resulting in the Oral Chemotherapy Safety standards. Ms LeFebvre also discusses the importance of educating nurses in the area of prescribing and administering of the oral chemotherapy drugs.

Anita Margulies talks to ecancer at the 8th European Oncology Nursing Society (EONS) annual meeting in Geneva, April 2012. EONS and the Oncology Nursing Society are implementing guidelines on 5 symptoms resulting from the cancer itself and the treatment: Dyspnea, lymphoedema, pain, peripheral neuropathy and radiation dermatitis. The guidelines have been reviewed by an expert nursing committee as part of the EPAAC project. Europe lags behind the US in implementing the latest guidelines on symptom management for cancer patients; a training workshop has been set up in Brussels to address this issue.

Fatigue is the most common side effect cancer patients face during and after treatment. April is National Cancer Fatigue Awareness month, and in this episode we will explore what you or a loved one can do to combat this frequent symptom. We'll also discuss how to manage other common side effects, such as loss or hair and nausea, and provide helpful tips on how you can cope. Guests include Astrid Nicastri, 2-time cancer survivor and participant at The Wellness Community-Greater Miami; and Ruth Gholz, RN, MS, AOCN, who works for the Veterans Affairs and also sits on the Board of the Oncology Nursing Society.